Data:AXA/2025/FY/Financial supplement.json: Difference between revisions
Appearance
Content deleted Content added
Section records derived from the published summary page (21 sections) |
Section records derived from the published summary page (21 sections) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
"document_name": "AXA FY 2025 Financial Supplement (Excel)", |
"document_name": "AXA FY 2025 Financial Supplement (Excel)", |
||
"publication_date": "2026-02-26", |
"publication_date": "2026-02-26", |
||
"language": "English", |
|||
"intro_sentence": "This article summarizes AXA's Financial supplement published on 2026-02-26 (21 pages)." |
"intro_sentence": "This article summarizes AXA's Financial supplement published on 2026-02-26 (21 pages)." |
||
}, |
}, |
||
| Line 39: | Line 40: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
| ⚫ | |||
"Underlying earnings", |
"Underlying earnings", |
||
"Business |
"Business mix", |
||
| ⚫ | |||
"Property \u0026 casualty", |
|||
"Life \u0026 health", |
|||
"AXA Investment Managers", |
"AXA Investment Managers", |
||
"Full year 2024", |
"Full year 2024", |
||
| Line 52: | Line 55: | ||
"AXA", |
"AXA", |
||
"AXA Investment Managers", |
"AXA Investment Managers", |
||
"Business |
"Business mix", |
||
"Foreign exchange", |
"Foreign exchange", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Life \u0026 health", |
|||
"Other revenue", |
"Other revenue", |
||
"Property \u0026 casualty", |
|||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Group |
"content": "**Group underlying earnings build-up by line of business (Business mix) and net income**\n\n| In EUR million | Group (AXA) 1H24 | Group (AXA) FY24 (Full year 2024) | Group (AXA) 1H25 | Group (AXA) FY25 (Full year 2025) | Property \u0026 Casualty (Property \u0026 casualty) 1H24 | Property \u0026 Casualty (Property \u0026 casualty) FY24 | Property \u0026 Casualty (Property \u0026 casualty) 1H25 | Property \u0026 Casualty (Property \u0026 casualty) FY25 | Life \u0026 Health (Life \u0026 health) 1H24 | Life \u0026 Health (Life \u0026 health) FY24 | Life \u0026 Health (Life \u0026 health) 1H25 | Life \u0026 Health (Life \u0026 health) FY25 | Asset Management (AXA Investment Managers) (1) 1H24 | Asset Management (AXA Investment Managers) (1) FY24 | Asset Management (AXA Investment Managers) (1) 1H25 | Asset Management (AXA Investment Managers) (1) FY25 | Holdings (2) 1H24 | Holdings (2) FY24 | Holdings (2) 1H25 | Holdings (2) FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 35,273 | 72,104 | 37,209 | 75,071 | 27,294 | 55,898 | 28,697 | 57,656 | 7,979 | 16,207 | 8,512 | 17,416 | — | — | — | — | — | — | — | — |\n| Short-term Business — Combined Ratio | — | — | — | — | 90.2% | 91.0% | 90.0% | 90.6% | 97.6% | 97.4% | 97.1% | 97.2% | — | — | — | — | — | — | — | — |\n| Short-term Business — Technical Margin | 2,877 | 5,421 | 3,107 | 5,888 | 2,682 | 5,006 | 2,859 | 5,409 | 195 | 415 | 248 | 479 | — | — | — | — | — | — | — | — |\n| Long-term Business — CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | — | — | — | — | 1,395 | 2,775 | 1,428 | 2,954 | — | — | — | — | — | — | — | — |\n| Long-term Business — Technical Experience | -64 | -95 | -30 | -150 | — | — | — | — | -64 | -95 | -30 | -150 | — | — | — | — | — | — | — | — |\n| Financial Result \u0026 Other — Financial Result | 2,064 | 3,971 | 2,148 | 4,013 | 1,324 | 2,559 | 1,343 | 2,631 | 536 | 975 | 563 | 946 | 24 | 35 | 14 | 14 | 181 | 402 | 228 | 422 |\n| Financial Result \u0026 Other — Other Revenues | 1,459 | 3,054 | 1,625 | 2,167 | — | — | — | — | — | — | — | — | 937 | 2,004 | 1,018 | 1,018 | 522 | 1,050 | 607 | 1,149 |\n| Financial Result \u0026 Other — Other Expenses | -1,624 | -3,479 | -1,868 | -2,900 | — | — | — | — | — | — | — | — | -698 | -1,493 | -793 | -793 | -925 | -1,986 | -1,075 | -2,107 |\n| Financial Result \u0026 Other — Debt Financing Charges | -471 | -948 | -452 | -928 | — | — | — | — | — | — | — | — | — | — | — | — | -471 | -948 | -452 | -928 |\n| **Financial Result \u0026 Other — Underlying Earnings Before Tax** | 5,638 | 10,700 | 5,958 | 11,044 | 4,006 | 7,565 | 4,202 | 8,040 | 2,061 | 4,070 | 2,209 | 4,229 | 263 | 546 | 239 | 239 | -693 | -1,482 | -692 | -1,464 |\n| Financial Result \u0026 Other — Tax | -1,427 | -2,662 | -1,503 | -2,644 | -1,046 | -1,952 | -1,074 | -2,060 | -412 | -874 | -462 | -800 | -69 | -160 | -68 | -68 | 100 | 324 | 101 | 284 |\n| Financial Result \u0026 Other — Income from Affiliates \u0026 Other | 122 | 218 | 111 | 168 | 2 | 3 | 1 | 3 | 103 | 186 | 101 | 157 | 16 | 29 | 8 | 8 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Minority Interests | -89 | -179 | -101 | -199 | -56 | -106 | -63 | -111 | -27 | -60 | -34 | -85 | -6 | -13 | -4 | -4 | 0 | 0 | 0 | 0 |\n| **Financial Result \u0026 Other — Underlying Earnings Group Share (Underlying earnings)** | 4,244 | 8,078 | 4,465 | 8,368 | 2,908 | 5,510 | 3,067 | 5,872 | 1,725 | 3,323 | 1,814 | 3,501 | 204 | 402 | 175 | 175 | -592 | -1,157 | -591 | -1,180 |\n| Financial Result \u0026 Other — Underlying Earnings Growth Rate (constant FX (Foreign exchange)) | 4% | 7% | 6% | 6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| **Financial Result \u0026 Other — Underlying ROE** | 16.6% | 15.2% | 17.5% | 16.0% | — | 16.2% | — | 17.3% | — | 13.6% | — | 14.4% | — | 26.0% | — | n.a. | — | — | — | — |\n| Financial Result \u0026 Other — Net Realized Capital Gains \u0026 Losses | 93 | 195 | 66 | 138 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Financial Result \u0026 Other — Change in Fair Value of Assets \u0026 Derivatives | -43 | 83 | -467 | -813 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Financial Result \u0026 Other — Amortization of customer intangibles | -50 | -131 | -48 | -86 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Financial Result \u0026 Other — Integration and Restructuring Costs | -78 | -240 | -63 | -197 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Financial Result \u0026 Other — Exceptional Items | -147 | -99 | -30 | 2,386 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| **Financial Result \u0026 Other — Net Income Group Share** | 4,020 | 7,886 | 3,922 | 9,797 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Financial Result \u0026 Other — Deeply Subordinated and Undated Subordinated Debt Charges | -106 | -201 | -86 | -174 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| **Financial Result \u0026 Other — Underlying Earnings for EPS calculation** | 4,138 | 7,877 | 4,379 | 8,195 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| **Financial Result \u0026 Other — Net Income for EPS calculation** | 3,914 | 7,685 | 3,836 | 9,623 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n\n(1) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.\n(2) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25." |
||
}, |
}, |
||
{ |
{ |
||
| Line 75: | Line 80: | ||
"AXA Europe", |
"AXA Europe", |
||
"AXA XL", |
"AXA XL", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Investment Managers", |
"AXA Investment Managers", |
||
"AXA Transversal \u0026 Other", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Other revenue", |
"Other revenue", |
||
"Business |
"Business mix", |
||
"Property \u0026 casualty", |
|||
"Life \u0026 health" |
|||
], |
], |
||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
"AXA", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Europe", |
"AXA Europe", |
||
"AXA France", |
"AXA France", |
||
"AXA Investment Managers", |
"AXA Investment Managers", |
||
"AXA Transversal \u0026 Other", |
|||
"AXA XL", |
"AXA XL", |
||
"Business |
"Business mix", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Life \u0026 health", |
|||
"Other revenue", |
"Other revenue", |
||
"Property \u0026 casualty", |
|||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Underlying earnings build-up by geography**\n\n| In EUR million | Group (AXA) 1H24 | Group (AXA) FY24 (Full year 2024) | Group (AXA) 1H25 | Group (AXA) FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM 1H24 | Asia, Africa \u0026 EME-LATAM FY24 | Asia, Africa \u0026 EME-LATAM 1H25 | Asia, Africa \u0026 EME-LATAM FY25 | AXA IM (AXA Investment Managers) (3) 1H24 | AXA IM (AXA Investment Managers) (3) FY24 | AXA IM (AXA Investment Managers) (3) 1H25 | AXA IM (AXA Investment Managers) (3) FY25 | Transversal \u0026 Other 1H24 | Transversal \u0026 Other FY24 | Transversal \u0026 Other 1H25 | Transversal \u0026 Other FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 35,273 | 72,104 | 37,209 | 75,071 | 9,046 | 18,698 | 9,567 | 19,555 | 11,839 | 24,005 | 12,661 | 25,724 | 9,022 | 18,530 | 9,428 | 18,699 | 4,312 | 8,750 | 4,478 | 8,986 | — | — | — | — | 1,053 | 2,122 | 1,075 | 2,107 |\n| Combined Ratio — Technical Margin | 2,877 | 5,421 | 3,107 | 5,888 | 692 | 1,470 | 658 | 1,485 | 998 | 1,957 | 1,176 | 2,357 | 1,111 | 1,820 | 1,074 | 1,928 | 70 | 81 | 150 | 9 | — | — | — | — | 6 | 93 | 49 | 109 |\n| Long-term Business — CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | — | — | — | — | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | — | — | — | — | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 2,064 | 3,971 | 2,148 | 4,013 | 350 | 613 | 380 | 667 | 784 | 1,486 | 765 | 1,398 | 283 | 616 | 308 | 651 | 382 | 741 | 425 | 782 | 24 | 35 | 14 | 14 | 241 | 480 | 255 | 502 |\n| Financial Result \u0026 Other — Other Revenues | 1,459 | 3,054 | 1,625 | 2,167 | 53 | 108 | 44 | 91 | -18 | -32 | -8 | -12 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -3 | 937 | 2,004 | 1,018 | 1,018 | 488 | 974 | 573 | 1,073 |\n| Financial Result \u0026 Other — Other Expenses | -1,624 | -3,479 | -1,868 | -2,900 | -83 | -180 | -79 | -168 | -10 | -25 | -6 | -3 | 0 | 0 | 0 | 0 | -9 | -20 | -14 | -26 | -698 | -1,493 | -793 | -793 | -823 | -1,761 | -976 | -1,910 |\n| Financial Result \u0026 Other — Debt Financing Charges | -471 | -948 | -452 | -928 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | -2 | -16 | -33 | -16 | -32 | -7 | -12 | -4 | -6 | — | — | — | — | -447 | -902 | -431 | -887 |\n| **Financial Result \u0026 Other — Underlying Earnings Before Tax** | 5,638 | 10,700 | 5,958 | 11,044 | 1,380 | 2,738 | 1,384 | 2,888 | 2,210 | 4,297 | 2,406 | 4,651 | 1,385 | 2,409 | 1,366 | 2,543 | 935 | 1,826 | 1,093 | 1,835 | 263 | 546 | 239 | 239 | -535 | -1,116 | -530 | -1,113 |\n| Financial Result \u0026 Other — Tax | -1,427 | -2,662 | -1,503 | -2,644 | -350 | -676 | -308 | -665 | -536 | -1,004 | -568 | -1,039 | -355 | -588 | -342 | -650 | -205 | -443 | -294 | -434 | -69 | -160 | -68 | -68 | 88 | 209 | 76 | 212 |\n| Financial Result \u0026 Other — Income from Affiliates \u0026 Other | 122 | 218 | 111 | 168 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102 | 181 | 103 | 160 | 16 | 29 | 8 | 8 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Minority Interests | -89 | -179 | -101 | -199 | 0 | 0 | 0 | 0 | -48 | -105 | -56 | -126 | 0 | 0 | 0 | 0 | -34 | -60 | -39 | -68 | -6 | -13 | -4 | -4 | 0 | 0 | -1 | -2 |\n| **Financial Result \u0026 Other — Underlying Earnings Group share (Underlying earnings)** | 4,244 | 8,078 | 4,465 | 8,368 | 1,034 | 2,071 | 1,076 | 2,224 | 1,626 | 3,187 | 1,782 | 3,486 | 1,030 | 1,820 | 1,024 | 1,893 | 798 | 1,504 | 862 | 1,493 | 204 | 402 | 175 | 175 | -447 | -907 | -455 | -903 |\n\n**Underlying earnings by line of business (Business |
"content": "**Underlying earnings build-up by geography**\n\n| In EUR million | Group (AXA) 1H24 | Group (AXA) FY24 (Full year 2024) | Group (AXA) 1H25 | Group (AXA) FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY25 | AXA IM (AXA Investment Managers) (3) 1H24 | AXA IM (AXA Investment Managers) (3) FY24 | AXA IM (AXA Investment Managers) (3) 1H25 | AXA IM (AXA Investment Managers) (3) FY25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 35,273 | 72,104 | 37,209 | 75,071 | 9,046 | 18,698 | 9,567 | 19,555 | 11,839 | 24,005 | 12,661 | 25,724 | 9,022 | 18,530 | 9,428 | 18,699 | 4,312 | 8,750 | 4,478 | 8,986 | — | — | — | — | 1,053 | 2,122 | 1,075 | 2,107 |\n| Combined Ratio — Technical Margin | 2,877 | 5,421 | 3,107 | 5,888 | 692 | 1,470 | 658 | 1,485 | 998 | 1,957 | 1,176 | 2,357 | 1,111 | 1,820 | 1,074 | 1,928 | 70 | 81 | 150 | 9 | — | — | — | — | 6 | 93 | 49 | 109 |\n| Long-term Business — CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | — | — | — | — | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | — | — | — | — | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 2,064 | 3,971 | 2,148 | 4,013 | 350 | 613 | 380 | 667 | 784 | 1,486 | 765 | 1,398 | 283 | 616 | 308 | 651 | 382 | 741 | 425 | 782 | 24 | 35 | 14 | 14 | 241 | 480 | 255 | 502 |\n| Financial Result \u0026 Other — Other Revenues | 1,459 | 3,054 | 1,625 | 2,167 | 53 | 108 | 44 | 91 | -18 | -32 | -8 | -12 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -3 | 937 | 2,004 | 1,018 | 1,018 | 488 | 974 | 573 | 1,073 |\n| Financial Result \u0026 Other — Other Expenses | -1,624 | -3,479 | -1,868 | -2,900 | -83 | -180 | -79 | -168 | -10 | -25 | -6 | -3 | 0 | 0 | 0 | 0 | -9 | -20 | -14 | -26 | -698 | -1,493 | -793 | -793 | -823 | -1,761 | -976 | -1,910 |\n| Financial Result \u0026 Other — Debt Financing Charges | -471 | -948 | -452 | -928 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | -2 | -16 | -33 | -16 | -32 | -7 | -12 | -4 | -6 | — | — | — | — | -447 | -902 | -431 | -887 |\n| **Financial Result \u0026 Other — Underlying Earnings Before Tax** | 5,638 | 10,700 | 5,958 | 11,044 | 1,380 | 2,738 | 1,384 | 2,888 | 2,210 | 4,297 | 2,406 | 4,651 | 1,385 | 2,409 | 1,366 | 2,543 | 935 | 1,826 | 1,093 | 1,835 | 263 | 546 | 239 | 239 | -535 | -1,116 | -530 | -1,113 |\n| Financial Result \u0026 Other — Tax | -1,427 | -2,662 | -1,503 | -2,644 | -350 | -676 | -308 | -665 | -536 | -1,004 | -568 | -1,039 | -355 | -588 | -342 | -650 | -205 | -443 | -294 | -434 | -69 | -160 | -68 | -68 | 88 | 209 | 76 | 212 |\n| Financial Result \u0026 Other — Income from Affiliates \u0026 Other | 122 | 218 | 111 | 168 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102 | 181 | 103 | 160 | 16 | 29 | 8 | 8 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Minority Interests | -89 | -179 | -101 | -199 | 0 | 0 | 0 | 0 | -48 | -105 | -56 | -126 | 0 | 0 | 0 | 0 | -34 | -60 | -39 | -68 | -6 | -13 | -4 | -4 | 0 | 0 | -1 | -2 |\n| **Financial Result \u0026 Other — Underlying Earnings Group share (Underlying earnings)** | 4,244 | 8,078 | 4,465 | 8,368 | 1,034 | 2,071 | 1,076 | 2,224 | 1,626 | 3,187 | 1,782 | 3,486 | 1,030 | 1,820 | 1,024 | 1,893 | 798 | 1,504 | 862 | 1,493 | 204 | 402 | 175 | 175 | -447 | -907 | -455 | -903 |\n\n**Underlying earnings by line of business (Business mix) and geography**\n\n| In EUR million | Group 1H24 | Group FY24 | Group 1H25 | Group FY25 | France 1H24 | France FY24 | France 1H25 | France FY25 | Europe 1H24 | Europe FY24 | Europe 1H25 | Europe FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM 1H24 | Asia, Africa \u0026 EME-LATAM FY24 | Asia, Africa \u0026 EME-LATAM 1H25 | Asia, Africa \u0026 EME-LATAM FY25 | AXA IM (3) 1H24 | AXA IM (3) FY24 | AXA IM (3) 1H25 | AXA IM (3) FY25 | Transversal \u0026 Other 1H24 | Transversal \u0026 Other FY24 | Transversal \u0026 Other 1H25 | Transversal \u0026 Other FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Underlying Earnings by Line of Business — Property \u0026 Casualty (Property \u0026 casualty) | 2,908 | 5,510 | 3,067 | 5,872 | 539 | 1,161 | 574 | 1,237 | 1,073 | 2,029 | 1,152 | 2,216 | 1,032 | 1,828 | 1,032 | 1,913 | 194 | 334 | 233 | 355 | — | — | — | — | 70 | 158 | 75 | 151 |\n| Underlying Earnings by Line of Business — Life \u0026 Health (Life \u0026 health) | 1,725 | 3,323 | 1,814 | 3,501 | 519 | 964 | 524 | 1,039 | 559 | 1,104 | 616 | 1,264 | 14 | 25 | 8 | 12 | 627 | 1,211 | 653 | 1,165 | — | — | — | — | 7 | 19 | 14 | 22 |\n| Underlying Earnings by Line of Business — Asset Management | 204 | 402 | 175 | 175 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 204 | 402 | 175 | 175 | — | — | — | — |\n| Underlying Earnings by Line of Business — Holdings (4) | -592 | -1,157 | -591 | -1,180 | -24 | -54 | -23 | -52 | -6 | 54 | 14 | 6 | -16 | -33 | -16 | -32 | -23 | -41 | -24 | -26 | — | — | — | — | -524 | -1,083 | -543 | -1,076 |\n\n(3) AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.\n(4) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25." |
||
}, |
}, |
||
{ |
{ |
||
| Line 107: | Line 120: | ||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"AXA", |
|||
"Underlying earnings", |
"Underlying earnings", |
||
"Underlying earnings per share" |
"Underlying earnings per share" |
||
| Line 113: | Line 125: | ||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
| Line 119: | Line 130: | ||
"Underlying earnings per share" |
"Underlying earnings per share" |
||
], |
], |
||
"content": "**Basic number of shares rollforward**\n\n| million | Outstanding Shares Excluding Treasury Shares (5) FY24 (Full year 2024) | Outstanding Shares Excluding Treasury Shares (5) FY25 (Full year 2025) | Weighted Average Number FY24 | Weighted Average Number FY25 |\n| --- | --- | --- | --- | --- |\n| **Basic Number of Shares — As of Beginning of Period** | 2,226.2 | 2,175.4 | 2,226.2 | 2,175.4 |\n| Basic Number of Shares — Increase of Capital Dedicated to Employees | 12.9 | 12.7 | 0.9 | 1.0 |\n| Basic Number of Shares — Exercice of Stock-options | 2.6 | 1.1 | 1.4 | 0.6 |\n| Basic Number of Shares — Other Movement of Treasury Shares | 4.6 | 4.2 | 17.5 | 6.3 |\n| Basic Number of Shares — Capital Increase / (Decrease) | -70.9 | -138.0 | -55.2 | -64.9 |\n| **Basic Number of Shares — As at End of Period** | 2,175.4 | 2,055.4 | — | — |\n| **Basic Number of Shares — During the Period** | — | — | 2,190.8 | 2,118.3 |\n| Fully Diluted Number of Shares — Stock Options | — | — | 0.8 | 0.6 |\n| Fully Diluted Number of Shares — Performance Shares | — | — | 5.6 | 5.1 |\n| **Fully Diluted Number of Shares — During the Period (A)** | — | — | 2,197.1 | 2,124.0 |\n| Earnings Group |
"content": "**Basic number of shares rollforward**\n\n| million | Outstanding Shares Excluding Treasury Shares (5) FY24 (Full year 2024) | Outstanding Shares Excluding Treasury Shares (5) FY25 (Full year 2025) | Weighted Average Number FY24 | Weighted Average Number FY25 |\n| --- | --- | --- | --- | --- |\n| **Basic Number of Shares — As of Beginning of Period** | 2,226.2 | 2,175.4 | 2,226.2 | 2,175.4 |\n| Basic Number of Shares — Increase of Capital Dedicated to Employees | 12.9 | 12.7 | 0.9 | 1.0 |\n| Basic Number of Shares — Exercice of Stock-options | 2.6 | 1.1 | 1.4 | 0.6 |\n| Basic Number of Shares — Other Movement of Treasury Shares | 4.6 | 4.2 | 17.5 | 6.3 |\n| Basic Number of Shares — Capital Increase / (Decrease) | -70.9 | -138.0 | -55.2 | -64.9 |\n| **Basic Number of Shares — As at End of Period** | 2,175.4 | 2,055.4 | — | — |\n| **Basic Number of Shares — During the Period** | — | — | 2,190.8 | 2,118.3 |\n| Fully Diluted Number of Shares — Stock Options | — | — | 0.8 | 0.6 |\n| Fully Diluted Number of Shares — Performance Shares | — | — | 5.6 | 5.1 |\n| **Fully Diluted Number of Shares — During the Period (A)** | — | — | 2,197.1 | 2,124.0 |\n| Earnings Group Share: — Net Income | — | — | 7,886 | 9,797 |\n| Earnings Group Share: — Underlying Earnings | — | — | 8,078 | 8,368 |\n| Impact of undated and deeply subordinated debts: — Undated and deeply subordinated debt charges | — | — | -201 | -174 |\n| Earnings for EPS Calculation: — Net Income for EPS Calculation (B) | — | — | 7,685 | 9,623 |\n| Earnings for EPS Calculation: — Underlying Earnings for EPS Calculation (C) | — | — | 7,877 | 8,195 |\n| **Fully Diluted Euro per Share (EPS) — EPS (B/A)** | — | — | 3.50 | 4.53 |\n| **Fully Diluted Euro per Share (EPS) — Underlying EPS (Underlying earnings per share) (C/A)** | — | — | 3.59 | 3.86 |\n\n(5) Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24." |
||
}, |
}, |
||
{ |
{ |
||
| Line 130: | Line 141: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
"Property \u0026 casualty", |
|||
"Underlying earnings", |
"Underlying earnings", |
||
"Business |
"Business mix", |
||
"AXA XL", |
"AXA XL", |
||
"Full year 2024", |
"Full year 2024", |
||
| Line 141: | Line 153: | ||
"AXA", |
"AXA", |
||
"AXA XL", |
"AXA XL", |
||
"Business |
"Business mix", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Other revenue", |
"Other revenue", |
||
"Property \u0026 casualty", |
|||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Property \u0026 casualty underlying earnings build-up by line of business (Business |
"content": "**Property \u0026 casualty (Property \u0026 casualty) underlying earnings build-up by line of business (Business mix)**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | Commercial lines 1H24 | Commercial lines FY24 | Commercial lines 1H25 | Commercial lines FY25 | Personal lines 1H24 | Personal lines FY24 | Personal lines 1H25 | Personal lines FY25 | AXA XL Reinsurance 1H24 | AXA XL Reinsurance FY24 | AXA XL Reinsurance 1H25 | AXA XL Reinsurance FY25 | Intercompany eliminations 1H24 | Intercompany eliminations FY24 | Intercompany eliminations 1H25 | Intercompany eliminations FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 27,294 | 55,898 | 28,697 | 57,656 | 18,657 | 38,019 | 19,575 | 39,090 | 9,144 | 18,705 | 9,513 | 19,276 | 1,155 | 2,394 | 1,299 | 2,493 | -1,662 | -3,220 | -1,689 | -3,203 |\n| Short-term Business — Current Accident Year Loss Ratio | 67.0% | 67.7% | 66.7% | 66.9% | 68.1% | 68.8% | 68.0% | 68.0% | 69.8% | 70.0% | 68.8% | 69.1% | 69.7% | 70.6% | 70.8% | 71.9% | — | — | — | — |\n| Short-term Business — Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) | 67.4% | 67.4% | 67.0% | 67.0% | 69.2% | 69.4% | 69.3% | 68.8% | 68.8% | 68.5% | 67.5% | 67.9% | 68.0% | 67.9% | 69.4% | 71.5% | — | — | — | — |\n| Short-term Business — Undiscounted Current Accident Year Nat Cats | 3.6% | 3.8% | 3.5% | 3.4% | 2.7% | 2.9% | 2.7% | 2.6% | 4.0% | 4.1% | 3.8% | 3.6% | 10.6% | 10.4% | 9.2% | 8.7% | — | — | — | — |\n| Short-term Business — Current Accident Year Discounting | -3.9% | -3.6% | -3.9% | -3.5% | -3.7% | -3.5% | -3.9% | -3.5% | -3.0% | -2.6% | -2.6% | -2.4% | -8.8% | -7.7% | -7.8% | -8.3% | — | — | — | — |\n| Short-term Business — Prior Year Reserve Development Ratio | -1.5% | -1.6% | -1.1% | -1.1% | -1.1% | -1.2% | -1.3% | -0.8% | -2.3% | -1.8% | -0.6% | -1.6% | -1.1% | -0.8% | -0.3% | 0.0% | — | — | — | — |\n| Short-term Business — Expense Ratio | 24.7% | 25.0% | 24.5% | 24.8% | 23.1% | 23.6% | 23.2% | 23.5% | 25.5% | 25.7% | 25.1% | 25.2% | 10.0% | 9.9% | 9.1% | 9.4% | — | — | — | — |\n| Short-term Business — Combined Ratio | 90.2% | 91.0% | 90.0% | 90.6% | 90.1% | 91.1% | 89.9% | 90.7% | 92.9% | 93.9% | 93.3% | 92.8% | 78.7% | 79.7% | 79.6% | 81.4% | — | — | — | — |\n| Short-term Business — Technical Margin | 2,682 | 5,006 | 2,859 | 5,409 | 1,850 | 3,372 | 1,968 | 3,616 | 645 | 1,136 | 638 | 1,392 | 246 | 486 | 265 | 464 | -60 | 12 | -12 | -63 |\n| Financial Result \u0026 Other — Financial Result | 1,324 | 2,559 | 1,343 | 2,631 | 993 | 1,831 | 1,004 | 1,941 | 240 | 538 | 275 | 523 | 119 | 210 | 85 | 186 | -28 | -20 | -20 | -20 |\n| Financial Result \u0026 Other — Investment Income | 1,967 | 3,731 | 2,088 | 3,988 | 1,427 | 2,625 | 1,512 | 2,864 | 366 | 761 | 422 | 794 | 202 | 365 | 174 | 350 | -28 | -20 | -20 | -20 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -643 | -1,172 | -745 | -1,358 | -434 | -794 | -508 | -922 | -126 | -223 | -148 | -272 | -83 | -155 | -90 | -163 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 4,006 | 7,565 | 4,202 | 8,040 | 2,843 | 5,203 | 2,973 | 5,557 | 886 | 1,674 | 913 | 1,914 | 365 | 696 | 349 | 650 | -87 | -8 | -33 | -82 |\n| Debt Financing Charges — Tax | -1,046 | -1,952 | -1,074 | -2,060 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 2 | 3 | 1 | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Debt Financing Charges — Minority Interests | -56 | -106 | -63 | -111 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 2,908 | 5,510 | 3,067 | 5,872 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| **Debt Financing Charges — Closing Invested Assets** | 113,515 | 118,104 | 116,895 | 117,507 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Debt Financing Charges — o/w VFA | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| Debt Financing Charges — o/w Non VFA | 113,515 | 118,104 | 116,895 | 117,507 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 19,284 | 16,006 | 19,766 | 16,040 | 12,070 | 9,480 | 12,240 | 9,127 | 6,369 | 5,478 | 6,831 | 5,871 | 1,572 | 1,075 | 1,436 | 1,009 | -728 | -27 | -740 | 32 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 69,800 | 71,751 | 70,215 | 70,567 | 45,710 | 46,570 | 46,591 | 47,002 | 17,809 | 18,308 | 17,781 | 17,402 | 6,704 | 6,830 | 6,290 | 6,198 | -423 | 43 | -447 | -35 |" |
||
}, |
}, |
||
{ |
{ |
||
| Line 158: | Line 171: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
"Property \u0026 casualty", |
|||
"Underlying earnings", |
"Underlying earnings", |
||
"AXA France", |
"AXA France", |
||
"AXA Europe", |
"AXA Europe", |
||
"AXA XL", |
"AXA XL", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Transversal \u0026 Other", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
| Line 169: | Line 185: | ||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
"AXA", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Europe", |
"AXA Europe", |
||
"AXA France", |
"AXA France", |
||
"AXA Transversal \u0026 Other", |
|||
"AXA XL", |
"AXA XL", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Other revenue", |
"Other revenue", |
||
"Property \u0026 casualty", |
|||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Property \u0026 casualty underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL o/w AXA XL Insurance | AXA XL FY24 | AXA XL o/w AXA XL Insurance | AXA XL 1H25 | AXA XL o/w AXA XL Insurance | AXA XL FY25 | AXA XL o/w AXA XL Insurance | Asia, Africa \u0026 EME-LATAM 1H24 | Asia, Africa \u0026 EME-LATAM FY24 | Asia, Africa \u0026 EME-LATAM 1H25 | Asia, Africa \u0026 EME-LATAM FY25 | Transversal \u0026 Other 1H24 | Transversal \u0026 Other FY24 | Transversal \u0026 Other 1H25 | Transversal \u0026 Other FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 27,294 | 55,898 | 28,697 | 57,656 | 4,393 | 9,194 | 4,697 | 9,768 | 10,060 | 20,400 | 10,610 | 21,305 | 9,022 | 7,867 | 18,530 | 16,136 | 9,428 | 8,129 | 18,699 | 16,207 | 2,855 | 5,825 | 2,975 | 5,949 | 963 | 1,948 | 987 | 1,935 |\n| Short-term Business — Current Accident Year Loss Ratio | 67.0% | 67.7% | 66.7% | 66.9% | 69.4% | 68.9% | 70.6% | 70.1% | 66.5% | 66.9% | 64.7% | 65.1% | 67.5% | 67.2% | 69.2% | 69.0% | 68.4% | 68.0% | 68.8% | 68.3% | 68.6% | 69.3% | 68.2% | 69.6% | 53.2% | 51.0% | 48.0% | 44.6% |\n| Short-term Business — Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) | 67.4% | 67.4% | 67.0% | 67.0% | 71.3% | 69.7% | 70.6% | 70.2% | 65.0% | 65.5% | 64.1% | 64.3% | 68.8% | 68.9% | 69.3% | 69.5% | 69.7% | 69.8% | 69.8% | 69.6% | 70.0% | 70.4% | 69.7% | 70.2% | 52.9% | 51.1% | 48.0% | 44.5% |\n| Short-term Business — Undiscounted Current Accident Year Nat Cats | 3.6% | 3.8% | 3.5% | 3.4% | 3.4% | 3.8% | 4.8% | 4.5% | 4.5% | 4.1% | 3.3% | 3.1% | 3.8% | 2.8% | 4.6% | 3.8% | 4.2% | 3.4% | 3.9% | 3.1% | 0.8% | 0.9% | 0.8% | 1.6% | 1.4% | 1.1% | 1.3% | 1.2% |\n| Short-term Business — Current Accident Year Discounting | -3.9% | -3.6% | -3.9% | -3.5% | -5.3% | -4.6% | -4.8% | -4.6% | -3.1% | -2.8% | -2.7% | -2.3% | -5.1% | -4.6% | -4.7% | -4.2% | -5.5% | -5.2% | -4.9% | -4.4% | -2.2% | -2.0% | -2.3% | -2.2% | -1.1% | -1.2% | -1.2% | -1.1% |\n| Short-term Business — Prior Year Reserve Development Ratio | -1.5% | -1.6% | -1.1% | -1.1% | -3.5% | -3.9% | -2.6% | -2.9% | -2.1% | -2.1% | -1.1% | -1.3% | -0.1% | 0.0% | -0.1% | 0.0% | -0.2% | -0.2% | 0.0% | 0.0% | -0.1% | 0.1% | -1.0% | -0.2% | -3.7% | -5.7% | -4.0% | -1.9% |\n| Short-term Business — Expense Ratio | 24.7% | 25.0% | 24.5% | 24.8% | 21.9% | 21.9% | 20.7% | 20.4% | 25.9% | 26.2% | 26.0% | 26.2% | 20.3% | 21.8% | 21.0% | 22.7% | 20.4% | 22.2% | 20.9% | 22.6% | 29.4% | 29.6% | 29.0% | 29.8% | 50.5% | 50.9% | 52.5% | 52.8% |\n| Short-term Business — Combined Ratio | 90.2% | 91.0% | 90.0% | 90.6% | 87.8% | 86.8% | 88.6% | 87.5% | 90.3% | 91.0% | 89.6% | 90.0% | 87.7% | 89.0% | 90.2% | 91.7% | 88.6% | 90.0% | 89.7% | 91.0% | 98.0% | 99.1% | 96.2% | 99.2% | 100.1% | 96.2% | 96.5% | 95.5% |\n| Short-term Business — Technical Margin | 2,682 | 5,006 | 2,859 | 5,409 | 538 | 1,212 | 533 | 1,220 | 977 | 1,844 | 1,104 | 2,127 | 1,111 | 865 | 1,820 | 1,335 | 1,074 | 809 | 1,928 | 1,464 | 57 | 55 | 114 | 48 | -1 | 74 | 35 | 86 |\n| Financial Result \u0026 Other — Financial Result | 1,324 | 2,559 | 1,343 | 2,631 | 251 | 421 | 261 | 468 | 473 | 912 | 461 | 876 | 273 | 159 | 596 | 387 | 298 | 213 | 632 | 445 | 242 | 484 | 261 | 530 | 86 | 146 | 62 | 125 |\n| Financial Result \u0026 Other — Investment Income | 1,967 | 3,731 | 2,088 | 3,988 | 334 | 572 | 373 | 675 | 658 | 1,244 | 667 | 1,257 | 614 | 416 | 1,233 | 868 | 681 | 507 | 1,331 | 981 | 261 | 518 | 292 | 585 | 100 | 164 | 74 | 140 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -643 | -1,172 | -745 | -1,358 | -83 | -151 | -112 | -207 | -185 | -332 | -206 | -381 | -341 | -257 | -637 | -481 | -384 | -294 | -699 | -536 | -20 | -35 | -31 | -55 | -14 | -18 | -12 | -15 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 4,006 | 7,565 | 4,202 | 8,040 | 788 | 1,633 | 794 | 1,688 | 1,450 | 2,757 | 1,564 | 3,002 | 1,384 | 1,024 | 2,417 | 1,721 | 1,372 | 1,022 | 2,560 | 1,910 | 299 | 539 | 375 | 579 | 85 | 220 | 97 | 211 |\n| Debt Financing Charges — Tax | -1,046 | -1,952 | -1,074 | -2,060 | -249 | -472 | -220 | -451 | -352 | -671 | -384 | -734 | -352 | -257 | -588 | -457 | -339 | -252 | -647 | -482 | -77 | -159 | -110 | -170 | -15 | -62 | -21 | -58 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | -56 | -106 | -63 | -111 | 0 | 0 | 0 | 0 | -25 | -57 | -28 | -52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30 | -49 | -34 | -57 | 0 | 0 | -1 | -2 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 2,908 | 5,510 | 3,067 | 5,872 | 539 | 1,161 | 574 | 1,237 | 1,073 | 2,029 | 1,152 | 2,216 | 1,032 | 767 | 1,828 | 1,264 | 1,032 | 770 | 1,913 | 1,427 | 194 | 334 | 233 | 355 | 70 | 158 | 75 | 151 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 19,284 | 16,006 | 19,766 | 16,040 | 2,153 | 1,712 | 2,221 | 1,783 | 7,151 | 5,166 | 7,591 | 5,534 | 7,478 | 5,905 | 7,028 | 5,948 | 7,315 | 5,879 | 6,467 | 5,461 | 1,802 | 1,834 | 1,935 | 2,024 | 700 | 266 | 705 | 231 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 69,800 | 71,751 | 70,215 | 70,567 | 13,485 | 13,889 | 13,900 | 13,882 | 24,834 | 25,955 | 26,003 | 25,737 | 24,865 | 18,223 | 25,915 | 19,146 | 24,533 | 18,295 | 25,044 | 18,897 | 3,385 | 3,640 | 3,510 | 3,804 | 3,231 | 2,351 | 2,269 | 2,101 |" |
"content": "**Property \u0026 casualty (Property \u0026 casualty) underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL o/w AXA XL Insurance | AXA XL FY24 | AXA XL o/w AXA XL Insurance | AXA XL 1H25 | AXA XL o/w AXA XL Insurance | AXA XL FY25 | AXA XL o/w AXA XL Insurance | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 27,294 | 55,898 | 28,697 | 57,656 | 4,393 | 9,194 | 4,697 | 9,768 | 10,060 | 20,400 | 10,610 | 21,305 | 9,022 | 7,867 | 18,530 | 16,136 | 9,428 | 8,129 | 18,699 | 16,207 | 2,855 | 5,825 | 2,975 | 5,949 | 963 | 1,948 | 987 | 1,935 |\n| Short-term Business — Current Accident Year Loss Ratio | 67.0% | 67.7% | 66.7% | 66.9% | 69.4% | 68.9% | 70.6% | 70.1% | 66.5% | 66.9% | 64.7% | 65.1% | 67.5% | 67.2% | 69.2% | 69.0% | 68.4% | 68.0% | 68.8% | 68.3% | 68.6% | 69.3% | 68.2% | 69.6% | 53.2% | 51.0% | 48.0% | 44.6% |\n| Short-term Business — Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) | 67.4% | 67.4% | 67.0% | 67.0% | 71.3% | 69.7% | 70.6% | 70.2% | 65.0% | 65.5% | 64.1% | 64.3% | 68.8% | 68.9% | 69.3% | 69.5% | 69.7% | 69.8% | 69.8% | 69.6% | 70.0% | 70.4% | 69.7% | 70.2% | 52.9% | 51.1% | 48.0% | 44.5% |\n| Short-term Business — Undiscounted Current Accident Year Nat Cats | 3.6% | 3.8% | 3.5% | 3.4% | 3.4% | 3.8% | 4.8% | 4.5% | 4.5% | 4.1% | 3.3% | 3.1% | 3.8% | 2.8% | 4.6% | 3.8% | 4.2% | 3.4% | 3.9% | 3.1% | 0.8% | 0.9% | 0.8% | 1.6% | 1.4% | 1.1% | 1.3% | 1.2% |\n| Short-term Business — Current Accident Year Discounting | -3.9% | -3.6% | -3.9% | -3.5% | -5.3% | -4.6% | -4.8% | -4.6% | -3.1% | -2.8% | -2.7% | -2.3% | -5.1% | -4.6% | -4.7% | -4.2% | -5.5% | -5.2% | -4.9% | -4.4% | -2.2% | -2.0% | -2.3% | -2.2% | -1.1% | -1.2% | -1.2% | -1.1% |\n| Short-term Business — Prior Year Reserve Development Ratio | -1.5% | -1.6% | -1.1% | -1.1% | -3.5% | -3.9% | -2.6% | -2.9% | -2.1% | -2.1% | -1.1% | -1.3% | -0.1% | 0.0% | -0.1% | 0.0% | -0.2% | -0.2% | 0.0% | 0.0% | -0.1% | 0.1% | -1.0% | -0.2% | -3.7% | -5.7% | -4.0% | -1.9% |\n| Short-term Business — Expense Ratio | 24.7% | 25.0% | 24.5% | 24.8% | 21.9% | 21.9% | 20.7% | 20.4% | 25.9% | 26.2% | 26.0% | 26.2% | 20.3% | 21.8% | 21.0% | 22.7% | 20.4% | 22.2% | 20.9% | 22.6% | 29.4% | 29.6% | 29.0% | 29.8% | 50.5% | 50.9% | 52.5% | 52.8% |\n| Short-term Business — Combined Ratio | 90.2% | 91.0% | 90.0% | 90.6% | 87.8% | 86.8% | 88.6% | 87.5% | 90.3% | 91.0% | 89.6% | 90.0% | 87.7% | 89.0% | 90.2% | 91.7% | 88.6% | 90.0% | 89.7% | 91.0% | 98.0% | 99.1% | 96.2% | 99.2% | 100.1% | 96.2% | 96.5% | 95.5% |\n| Short-term Business — Technical Margin | 2,682 | 5,006 | 2,859 | 5,409 | 538 | 1,212 | 533 | 1,220 | 977 | 1,844 | 1,104 | 2,127 | 1,111 | 865 | 1,820 | 1,335 | 1,074 | 809 | 1,928 | 1,464 | 57 | 55 | 114 | 48 | -1 | 74 | 35 | 86 |\n| Financial Result \u0026 Other — Financial Result | 1,324 | 2,559 | 1,343 | 2,631 | 251 | 421 | 261 | 468 | 473 | 912 | 461 | 876 | 273 | 159 | 596 | 387 | 298 | 213 | 632 | 445 | 242 | 484 | 261 | 530 | 86 | 146 | 62 | 125 |\n| Financial Result \u0026 Other — Investment Income | 1,967 | 3,731 | 2,088 | 3,988 | 334 | 572 | 373 | 675 | 658 | 1,244 | 667 | 1,257 | 614 | 416 | 1,233 | 868 | 681 | 507 | 1,331 | 981 | 261 | 518 | 292 | 585 | 100 | 164 | 74 | 140 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -643 | -1,172 | -745 | -1,358 | -83 | -151 | -112 | -207 | -185 | -332 | -206 | -381 | -341 | -257 | -637 | -481 | -384 | -294 | -699 | -536 | -20 | -35 | -31 | -55 | -14 | -18 | -12 | -15 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 4,006 | 7,565 | 4,202 | 8,040 | 788 | 1,633 | 794 | 1,688 | 1,450 | 2,757 | 1,564 | 3,002 | 1,384 | 1,024 | 2,417 | 1,721 | 1,372 | 1,022 | 2,560 | 1,910 | 299 | 539 | 375 | 579 | 85 | 220 | 97 | 211 |\n| Debt Financing Charges — Tax | -1,046 | -1,952 | -1,074 | -2,060 | -249 | -472 | -220 | -451 | -352 | -671 | -384 | -734 | -352 | -257 | -588 | -457 | -339 | -252 | -647 | -482 | -77 | -159 | -110 | -170 | -15 | -62 | -21 | -58 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | -56 | -106 | -63 | -111 | 0 | 0 | 0 | 0 | -25 | -57 | -28 | -52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30 | -49 | -34 | -57 | 0 | 0 | -1 | -2 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 2,908 | 5,510 | 3,067 | 5,872 | 539 | 1,161 | 574 | 1,237 | 1,073 | 2,029 | 1,152 | 2,216 | 1,032 | 767 | 1,828 | 1,264 | 1,032 | 770 | 1,913 | 1,427 | 194 | 334 | 233 | 355 | 70 | 158 | 75 | 151 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 19,284 | 16,006 | 19,766 | 16,040 | 2,153 | 1,712 | 2,221 | 1,783 | 7,151 | 5,166 | 7,591 | 5,534 | 7,478 | 5,905 | 7,028 | 5,948 | 7,315 | 5,879 | 6,467 | 5,461 | 1,802 | 1,834 | 1,935 | 2,024 | 700 | 266 | 705 | 231 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 69,800 | 71,751 | 70,215 | 70,567 | 13,485 | 13,889 | 13,900 | 13,882 | 24,834 | 25,955 | 26,003 | 25,737 | 24,865 | 18,223 | 25,915 | 19,146 | 24,533 | 18,295 | 25,044 | 18,897 | 3,385 | 3,640 | 3,510 | 3,804 | 3,231 | 2,351 | 2,269 | 2,101 |" |
||
}, |
}, |
||
{ |
{ |
||
| Line 188: | Line 207: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
"Life \u0026 health", |
|||
"Underlying earnings", |
"Underlying earnings", |
||
"Business |
"Business mix", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
| Line 196: | Line 216: | ||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
"Business |
"Business mix", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Life \u0026 health", |
|||
"Other revenue", |
"Other revenue", |
||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Life \u0026 health underlying earnings build-up by line of business (Business |
"content": "**Life \u0026 health (Life \u0026 health) underlying earnings build-up by line of business (Business mix)**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | Life 1H24 | Life FY24 | Life 1H25 | Life FY25 | Health 1H24 | Health FY24 | Health 1H25 | Health FY25 | Employee Benefits* (out of Total Life \u0026 Health) (6) 1H24 | Employee Benefits* (out of Total Life \u0026 Health) FY24 | Employee Benefits* (out of Total Life \u0026 Health) 1H25 | Employee Benefits* (out of Total Life \u0026 Health) FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 7,979 | 16,207 | 8,512 | 17,416 | 2,112 | 4,247 | 2,211 | 4,444 | 5,867 | 11,960 | 6,301 | 12,972 | 5,592 | 11,482 | 5,931 | 12,035 |\n| Short-term Business — Combined Ratio | 97.6% | 97.4% | 97.1% | 97.2% | 94.5% | 95.5% | 95.2% | 95.4% | 98.6% | 98.1% | 97.8% | 97.9% | 98.2% | 97.8% | 97.4% | 97.1% |\n| Short-term Business — Technical Margin | 195 | 415 | 248 | 479 | 116 | 191 | 107 | 206 | 79 | 224 | 141 | 273 | 101 | 248 | 156 | 347 |\n| Long-term Business — CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 1,136 | 2,253 | 1,158 | 2,415 | 259 | 522 | 270 | 539 | 58 | 110 | 59 | 107 |\n| Long-term Business — Technical Experience | -64 | -95 | -30 | -150 | -71 | -98 | -28 | -139 | 7 | 3 | -2 | -11 | 17 | 37 | 22 | 38 |\n| Long-term Business — Actual vs. Expected Cash Flows | 9 | -15 | 12 | 39 | -4 | -33 | 10 | 37 | 13 | 18 | 2 | 2 | -3 | -2 | -5 | -8 |\n| Long-term Business — Risk Adjustment Release | 30 | 59 | 44 | 72 | 25 | 51 | 37 | 59 | 4 | 8 | 7 | 13 | 2 | 4 | 7 | 8 |\n| Long-term Business — Changes in Onerous Contracts | -32 | 6 | -12 | -29 | -30 | 9 | -10 | -25 | -1 | -2 | -2 | -4 | 0 | 0 | 0 | 0 |\n| Long-term Business — Other Long-term | -72 | -145 | -74 | -232 | -63 | -124 | -65 | -211 | -8 | -21 | -9 | -22 | 19 | 35 | 20 | 38 |\n| Financial Result \u0026 Other — Financial Result | 536 | 975 | 563 | 946 | 454 | 799 | 462 | 738 | 82 | 176 | 101 | 209 | 75 | 157 | 91 | 175 |\n| Financial Result \u0026 Other — Investment Income | 1,319 | 2,525 | 1,329 | 2,484 | 1,159 | 2,209 | 1,159 | 2,142 | 160 | 317 | 170 | 341 | 219 | 429 | 232 | 456 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -783 | -1,551 | -767 | -1,538 | -705 | -1,410 | -697 | -1,405 | -78 | -140 | -69 | -133 | -144 | -272 | -141 | -281 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 2,061 | 4,070 | 2,209 | 4,229 | 1,634 | 3,145 | 1,699 | 3,219 | 427 | 925 | 510 | 1,010 | 252 | 552 | 328 | 666 |\n| Debt Financing Charges — Tax | -412 | -874 | -462 | -800 | -316 | -635 | -329 | -584 | -96 | -239 | -133 | -216 | -46 | -111 | -64 | -110 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 103 | 186 | 101 | 157 | 101 | 182 | 93 | 154 | 2 | 4 | 8 | 2 | — | — | — | — |\n| Debt Financing Charges — Minority Interests | -27 | -60 | -34 | -85 | -27 | -56 | -30 | -75 | 0 | -4 | -3 | -9 | — | — | — | — |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 1,725 | 3,323 | 1,814 | 3,501 | 1,392 | 2,636 | 1,433 | 2,715 | 333 | 687 | 381 | 787 | 205 | 441 | 264 | 556 |\n| **Debt Financing Charges — Closing Invested Assets** | 329,460 | 345,008 | 338,447 | 334,840 | — | — | — | — | — | — | — | — | — | — | — | — |\n| Debt Financing Charges — o/w VFA | 234,783 | 230,205 | 229,844 | 226,937 | — | — | — | — | — | — | — | — | — | — | — | — |\n| Debt Financing Charges — o/w Non VFA | 94,677 | 114,803 | 108,603 | 107,903 | — | — | — | — | — | — | — | — | — | — | — | — |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 2,446 | 2,096 | 2,856 | 2,511 | 157 | 96 | 105 | 21 | 2,289 | 2,000 | 2,750 | 2,490 | — | — | — | — |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 13,876 | 14,162 | 13,960 | 14,592 | 11,589 | 11,778 | 11,623 | 11,205 | 2,286 | 2,384 | 2,337 | 3,386 | — | — | — | — |\n| **For long-term business — Best Estimate Liabilities net of reinsurance** | 295,342 | 306,249 | 301,040 | 300,391 | 275,276 | 285,391 | 280,314 | 280,280 | 20,066 | 20,858 | 20,726 | 20,112 | — | — | — | — |\n| For long-term business — o/w VFA Gross of reinsurance | 264,013 | 273,094 | 266,960 | 271,902 | 243,037 | 251,273 | 244,964 | 250,326 | 20,977 | 21,821 | 21,996 | 21,576 | — | — | — | — |\n| For long-term business — o/w BBA Gross of reinsurance | 50,097 | 51,845 | 51,524 | 45,307 | 50,917 | 52,713 | 52,731 | 46,724 | -821 | -868 | -1,207 | -1,417 | — | — | — | — |\n| For long-term business — o/w Reinsurance | -18,768 | -18,690 | -17,443 | -16,817 | -18,679 | -18,595 | -17,381 | -16,770 | -90 | -95 | -62 | -47 | — | — | — | — |\n\n(6) Employee Benefits include Group Protection and Group Health contracts." |
||
}, |
}, |
||
{ |
{ |
||
| Line 213: | Line 234: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
"Life \u0026 health", |
|||
"Underlying earnings", |
"Underlying earnings", |
||
"AXA France", |
"AXA France", |
||
"AXA Europe", |
"AXA Europe", |
||
"AXA XL", |
"AXA XL", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Transversal \u0026 Other", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
| Line 224: | Line 248: | ||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
"AXA", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Europe", |
"AXA Europe", |
||
"AXA France", |
"AXA France", |
||
"AXA Transversal \u0026 Other", |
|||
"AXA XL", |
"AXA XL", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Life \u0026 health", |
|||
"Other revenue", |
"Other revenue", |
||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Life \u0026 health underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM 1H24 | Asia, Africa \u0026 EME-LATAM FY24 | Asia, Africa \u0026 EME-LATAM 1H25 | Asia, Africa \u0026 EME-LATAM FY25 | Transversal \u0026 Other 1H24 | Transversal \u0026 Other FY24 | Transversal \u0026 Other 1H25 | Transversal \u0026 Other FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 7,979 | 16,207 | 8,512 | 17,416 | 4,654 | 9,503 | 4,870 | 9,787 | 1,778 | 3,604 | 2,051 | 4,419 | 0 | 0 | 0 | 0 | 1,457 | 2,925 | 1,503 | 3,037 | 90 | 174 | 88 | 172 |\n| Short-term Business — Combined Ratio | 97.6% | 97.4% | 97.1% | 97.2% | 96.7% | 97.3% | 97.4% | 97.3% | 98.8% | 96.9% | 96.4% | 94.8% | 0.0% | 0.0% | 0.0% | 0.0% | 99.1% | 99.1% | 97.6% | 101.3% | 92.2% | 89.1% | 83.6% | 86.7% |\n| Short-term Business — Technical Margin | 195 | 415 | 248 | 479 | 155 | 258 | 124 | 265 | 21 | 113 | 73 | 230 | 0 | 0 | 0 | 0 | 13 | 26 | 36 | -39 | 7 | 19 | 14 | 23 |\n| Long-term Business — CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | 0 | 0 | 0 | 0 |\n| Long-term Business — Actual vs. Expected Cash Flows | 9 | -15 | 12 | 39 | 8 | -8 | 2 | 15 | 5 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | 0 | 8 | 22 | 35 | 0 | 0 | 0 | 0 |\n| Long-term Business — Risk Adjustment Release | 30 | 59 | 44 | 72 | 5 | 15 | 9 | 14 | 11 | 21 | 21 | 32 | 0 | 1 | 0 | 1 | 13 | 23 | 13 | 25 | 0 | 0 | 0 | 0 |\n| Long-term Business — Changes in Onerous Contracts | -32 | 6 | -12 | -29 | 0 | 0 | 0 | 0 | -33 | -25 | -13 | -36 | 5 | 5 | 0 | 0 | -3 | 26 | 1 | 7 | 0 | 0 | 0 | 0 |\n| Long-term Business — Other Long-term | -72 | -145 | -74 | -232 | -52 | -103 | -49 | -111 | 7 | 7 | 12 | -61 | 0 | 0 | 0 | 0 | -26 | -50 | -37 | -61 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 536 | 975 | 563 | 946 | 100 | 192 | 118 | 197 | 284 | 504 | 269 | 477 | 10 | 19 | 10 | 20 | 142 | 260 | 165 | 250 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Investment Income | 1,319 | 2,525 | 1,329 | 2,484 | 370 | 701 | 370 | 703 | 490 | 916 | 478 | 889 | 13 | 27 | 14 | 27 | 446 | 882 | 467 | 862 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -783 | -1,551 | -767 | -1,538 | -270 | -509 | -252 | -507 | -206 | -412 | -209 | -411 | -3 | -7 | -4 | -8 | -303 | -622 | -301 | -612 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 2,061 | 4,070 | 2,209 | 4,229 | 622 | 1,176 | 624 | 1,276 | 762 | 1,529 | 821 | 1,622 | 17 | 25 | 10 | 16 | 654 | 1,322 | 739 | 1,291 | 7 | 19 | 14 | 25 |\n| Debt Financing Charges — Tax | -412 | -874 | -462 | -800 | -106 | -220 | -100 | -237 | -180 | -376 | -176 | -285 | -3 | 0 | -2 | -4 | -123 | -277 | -182 | -272 | 0 | 0 | -1 | -4 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 103 | 186 | 101 | 157 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 177 | 101 | 157 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | -27 | -60 | -34 | -85 | 0 | 0 | 0 | 0 | -23 | -49 | -28 | -74 | 0 | 0 | 0 | 0 | -4 | -12 | -5 | -11 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 1,725 | 3,323 | 1,814 | 3,501 | 519 | 964 | 524 | 1,039 | 559 | 1,104 | 616 | 1,264 | 14 | 25 | 8 | 12 | 627 | 1,211 | 653 | 1,165 | 7 | 19 | 14 | 22 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 2,446 | 2,096 | 2,856 | 2,511 | 50 | -2 | 28 | -6 | 1,228 | 967 | 1,619 | 1,352 | 0 | 0 | 0 | 0 | 1,159 | 1,124 | 1,204 | 1,155 | 9 | 6 | 5 | 10 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 13,876 | 14,162 | 13,960 | 14,592 | 12,589 | 12,831 | 12,443 | 12,850 | 773 | 871 | 1,015 | 1,186 | 0 | 0 | 0 | 0 | 501 | 447 | 487 | 541 | 13 | 14 | 15 | 15 |\n| **For long-term business — Best Estimate Liabilities net of reinsurance** | 295,342 | 306,249 | 301,040 | 300,391 | 112,949 | 115,280 | 114,525 | 114,424 | 135,034 | 139,257 | 137,584 | 136,725 | 324 | 345 | 310 | 309 | 47,035 | 51,368 | 48,620 | 48,934 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w VFA Gross of reinsurance | 264,013 | 273,094 | 266,960 | 271,902 | 116,132 | 117,942 | 116,770 | 117,266 | 121,623 | 125,513 | 121,135 | 122,782 | 0 | 0 | 0 | 0 | 26,258 | 29,639 | 29,055 | 31,854 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w BBA Gross of reinsurance | 50,097 | 51,845 | 51,524 | 45,307 | 9,606 | 10,019 | 9,848 | 8,873 | 13,520 | 13,810 | 16,410 | 13,760 | 1,670 | 1,659 | 1,522 | 1,473 | 25,301 | 26,356 | 23,743 | 21,201 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w Reinsurance | -18,768 | -18,690 | -17,443 | -16,817 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,524 | -4,627 | -4,178 | -4,121 | 0 | 0 | 0 | 0 |" |
"content": "**Life \u0026 health (Life \u0026 health) underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 7,979 | 16,207 | 8,512 | 17,416 | 4,654 | 9,503 | 4,870 | 9,787 | 1,778 | 3,604 | 2,051 | 4,419 | 0 | 0 | 0 | 0 | 1,457 | 2,925 | 1,503 | 3,037 | 90 | 174 | 88 | 172 |\n| Short-term Business — Combined Ratio | 97.6% | 97.4% | 97.1% | 97.2% | 96.7% | 97.3% | 97.4% | 97.3% | 98.8% | 96.9% | 96.4% | 94.8% | 0.0% | 0.0% | 0.0% | 0.0% | 99.1% | 99.1% | 97.6% | 101.3% | 92.2% | 89.1% | 83.6% | 86.7% |\n| Short-term Business — Technical Margin | 195 | 415 | 248 | 479 | 155 | 258 | 124 | 265 | 21 | 113 | 73 | 230 | 0 | 0 | 0 | 0 | 13 | 26 | 36 | -39 | 7 | 19 | 14 | 23 |\n| Long-term Business — CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | 0 | 0 | 0 | 0 |\n| Long-term Business — Actual vs. Expected Cash Flows | 9 | -15 | 12 | 39 | 8 | -8 | 2 | 15 | 5 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | 0 | 8 | 22 | 35 | 0 | 0 | 0 | 0 |\n| Long-term Business — Risk Adjustment Release | 30 | 59 | 44 | 72 | 5 | 15 | 9 | 14 | 11 | 21 | 21 | 32 | 0 | 1 | 0 | 1 | 13 | 23 | 13 | 25 | 0 | 0 | 0 | 0 |\n| Long-term Business — Changes in Onerous Contracts | -32 | 6 | -12 | -29 | 0 | 0 | 0 | 0 | -33 | -25 | -13 | -36 | 5 | 5 | 0 | 0 | -3 | 26 | 1 | 7 | 0 | 0 | 0 | 0 |\n| Long-term Business — Other Long-term | -72 | -145 | -74 | -232 | -52 | -103 | -49 | -111 | 7 | 7 | 12 | -61 | 0 | 0 | 0 | 0 | -26 | -50 | -37 | -61 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 536 | 975 | 563 | 946 | 100 | 192 | 118 | 197 | 284 | 504 | 269 | 477 | 10 | 19 | 10 | 20 | 142 | 260 | 165 | 250 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Investment Income | 1,319 | 2,525 | 1,329 | 2,484 | 370 | 701 | 370 | 703 | 490 | 916 | 478 | 889 | 13 | 27 | 14 | 27 | 446 | 882 | 467 | 862 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -783 | -1,551 | -767 | -1,538 | -270 | -509 | -252 | -507 | -206 | -412 | -209 | -411 | -3 | -7 | -4 | -8 | -303 | -622 | -301 | -612 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 2,061 | 4,070 | 2,209 | 4,229 | 622 | 1,176 | 624 | 1,276 | 762 | 1,529 | 821 | 1,622 | 17 | 25 | 10 | 16 | 654 | 1,322 | 739 | 1,291 | 7 | 19 | 14 | 25 |\n| Debt Financing Charges — Tax | -412 | -874 | -462 | -800 | -106 | -220 | -100 | -237 | -180 | -376 | -176 | -285 | -3 | 0 | -2 | -4 | -123 | -277 | -182 | -272 | 0 | 0 | -1 | -4 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 103 | 186 | 101 | 157 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 177 | 101 | 157 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | -27 | -60 | -34 | -85 | 0 | 0 | 0 | 0 | -23 | -49 | -28 | -74 | 0 | 0 | 0 | 0 | -4 | -12 | -5 | -11 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 1,725 | 3,323 | 1,814 | 3,501 | 519 | 964 | 524 | 1,039 | 559 | 1,104 | 616 | 1,264 | 14 | 25 | 8 | 12 | 627 | 1,211 | 653 | 1,165 | 7 | 19 | 14 | 22 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 2,446 | 2,096 | 2,856 | 2,511 | 50 | -2 | 28 | -6 | 1,228 | 967 | 1,619 | 1,352 | 0 | 0 | 0 | 0 | 1,159 | 1,124 | 1,204 | 1,155 | 9 | 6 | 5 | 10 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 13,876 | 14,162 | 13,960 | 14,592 | 12,589 | 12,831 | 12,443 | 12,850 | 773 | 871 | 1,015 | 1,186 | 0 | 0 | 0 | 0 | 501 | 447 | 487 | 541 | 13 | 14 | 15 | 15 |\n| **For long-term business — Best Estimate Liabilities net of reinsurance** | 295,342 | 306,249 | 301,040 | 300,391 | 112,949 | 115,280 | 114,525 | 114,424 | 135,034 | 139,257 | 137,584 | 136,725 | 324 | 345 | 310 | 309 | 47,035 | 51,368 | 48,620 | 48,934 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w VFA Gross of reinsurance | 264,013 | 273,094 | 266,960 | 271,902 | 116,132 | 117,942 | 116,770 | 117,266 | 121,623 | 125,513 | 121,135 | 122,782 | 0 | 0 | 0 | 0 | 26,258 | 29,639 | 29,055 | 31,854 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w BBA Gross of reinsurance | 50,097 | 51,845 | 51,524 | 45,307 | 9,606 | 10,019 | 9,848 | 8,873 | 13,520 | 13,810 | 16,410 | 13,760 | 1,670 | 1,659 | 1,522 | 1,473 | 25,301 | 26,356 | 23,743 | 21,201 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w Reinsurance | -18,768 | -18,690 | -17,443 | -16,817 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,524 | -4,627 | -4,178 | -4,121 | 0 | 0 | 0 | 0 |" |
||
}, |
}, |
||
{ |
{ |
||
| Line 247: | Line 274: | ||
"AXA Europe", |
"AXA Europe", |
||
"AXA XL", |
"AXA XL", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Transversal \u0026 Other", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
| Line 254: | Line 283: | ||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
"AXA", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Europe", |
"AXA Europe", |
||
"AXA France", |
"AXA France", |
||
"AXA Transversal \u0026 Other", |
|||
"AXA XL", |
"AXA XL", |
||
"Full year 2024", |
"Full year 2024", |
||
| Line 262: | Line 293: | ||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Life underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM 1H24 | Asia, Africa \u0026 EME-LATAM FY24 | Asia, Africa \u0026 EME-LATAM 1H25 | Asia, Africa \u0026 EME-LATAM FY25 | Transversal \u0026 Other 1H24 | Transversal \u0026 Other FY24 | Transversal \u0026 Other 1H25 | Transversal \u0026 Other FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 2,112 | 4,247 | 2,211 | 4,444 | 1,902 | 3,843 | 2,005 | 4,044 | 53 | 109 | 54 | 106 | 0 | 0 | 0 | 0 | 157 | 296 | 152 | 295 | 0 | 0 | 0 | 0 |\n| Short-term Business — Combined Ratio | 94.5% | 95.5% | 95.2% | 95.4% | 95.1% | 96.3% | 95.9% | 96.1% | 79.8% | 77.0% | 79.0% | 77.3% | 0.0% | 0.0% | 0.0% | 0.0% | 92.3% | 91.5% | 91.5% | 91.6% | 0.0% | 0.0% | 0.0% | 0.0% |\n| Short-term Business — Technical Margin | 116 | 191 | 107 | 206 | 93 | 141 | 83 | 158 | 11 | 25 | 11 | 24 | 0 | 0 | 0 | 0 | 12 | 25 | 13 | 25 | 0 | 0 | 0 | 0 |\n| Long-term Business — CSM Release | 1,136 | 2,253 | 1,158 | 2,415 | 407 | 823 | 419 | 895 | 390 | 759 | 386 | 804 | 4 | 3 | 0 | 1 | 336 | 669 | 353 | 715 | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | -71 | -98 | -28 | -139 | -40 | -96 | -37 | -81 | -4 | 12 | 13 | -53 | 3 | 2 | 0 | -5 | -30 | -16 | -4 | 0 | 0 | 0 | 0 | 0 |\n| Long-term Business — Actual vs. Expected Cash Flows | -4 | -33 | 10 | 37 | 8 | -8 | 2 | 15 | 3 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | -12 | -10 | 20 | 33 | 0 | 0 | 0 | 0 |\n| Long-term Business — Risk Adjustment Release | 25 | 51 | 37 | 59 | 5 | 15 | 9 | 14 | 12 | 23 | 20 | 30 | 0 | 1 | 0 | 1 | 8 | 13 | 8 | 14 | 0 | 0 | 0 | 0 |\n| Long-term Business — Changes in Onerous Contracts | -30 | 9 | -10 | -25 | 0 | 0 | 0 | 0 | -32 | -23 | -13 | -33 | 5 | 5 | 0 | 0 | -3 | 26 | 3 | 8 | 0 | 0 | 0 | 0 |\n| Long-term Business — Other Long-term | -63 | -124 | -65 | -211 | -52 | -103 | -49 | -111 | 13 | 23 | 17 | -44 | 0 | 0 | 0 | 0 | -23 | -45 | -34 | -55 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 454 | 799 | 462 | 738 | 103 | 193 | 114 | 185 | 249 | 432 | 232 | 401 | 10 | 19 | 10 | 20 | 92 | 155 | 105 | 132 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Investment Income | 1,159 | 2,209 | 1,159 | 2,142 | 344 | 660 | 346 | 649 | 451 | 838 | 438 | 809 | 13 | 27 | 14 | 27 | 350 | 684 | 361 | 657 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -705 | -1,410 | -697 | -1,405 | -241 | -467 | -232 | -464 | -202 | -407 | -206 | -408 | -3 | -7 | -4 | -8 | -259 | -530 | -256 | -525 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 1,634 | 3,145 | 1,699 | 3,219 | 563 | 1,060 | 579 | 1,156 | 645 | 1,227 | 643 | 1,176 | 17 | 25 | 10 | 16 | 409 | 833 | 468 | 872 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Tax | -316 | -635 | -329 | -584 | -96 | -194 | -93 | -213 | -148 | -289 | -131 | -183 | -3 | 0 | -2 | -4 | -68 | -152 | -103 | -184 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 101 | 182 | 93 | 154 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97 | 173 | 93 | 154 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | -27 | -56 | -30 | -75 | 0 | 0 | 0 | 0 | -23 | -47 | -28 | -70 | 0 | 0 | 0 | 0 | -4 | -9 | -3 | -5 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 1,392 | 2,636 | 1,433 | 2,715 | 470 | 875 | 486 | 943 | 474 | 891 | 484 | 923 | 14 | 25 | 8 | 12 | 434 | 845 | 456 | 837 | 0 | 0 | 0 | 0 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 157 | 96 | 105 | 21 | 23 | -19 | 4 | -41 | -3 | -14 | -35 | -24 | 0 | 0 | 0 | 0 | 137 | 129 | 137 | 86 | 0 | 0 | 0 | 0 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 11,589 | 11,778 | 11,623 | 11,205 | 11,349 | 11,502 | 11,352 | 10,939 | 75 | 120 | 118 | 124 | 0 | 0 | 0 | 0 | 165 | 157 | 154 | 142 | 0 | 0 | 0 | 0 |\n| **For long-term business — Best Estimate Liabilities net of reinsurance** | 275,276 | 285,391 | 280,314 | 280,280 | 112,949 | 115,280 | 114,525 | 114,424 | 114,389 | 117,841 | 116,058 | 115,433 | 324 | 345 | 310 | 309 | 47,614 | 51,926 | 49,420 | 50,113 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w VFA Gross of reinsurance | 243,037 | 251,273 | 244,964 | 250,326 | 116,132 | 117,942 | 116,770 | 117,266 | 100,727 | 103,800 | 99,267 | 101,144 | 0 | 0 | 0 | 0 | 26,178 | 29,530 | 28,928 | 31,916 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w BBA Gross of reinsurance | 50,917 | 52,713 | 52,731 | 46,724 | 9,606 | 10,019 | 9,848 | 8,873 | 13,770 | 14,107 | 16,752 | 14,106 | 1,670 | 1,659 | 1,522 | 1,473 | 25,871 | 26,927 | 24,608 | 22,272 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w Reinsurance | -18,679 | -18,595 | -17,381 | -16,770 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,435 | -4,532 | -4,116 | -4,074 | 0 | 0 | 0 | 0 |" |
"content": "**Life underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 2,112 | 4,247 | 2,211 | 4,444 | 1,902 | 3,843 | 2,005 | 4,044 | 53 | 109 | 54 | 106 | 0 | 0 | 0 | 0 | 157 | 296 | 152 | 295 | 0 | 0 | 0 | 0 |\n| Short-term Business — Combined Ratio | 94.5% | 95.5% | 95.2% | 95.4% | 95.1% | 96.3% | 95.9% | 96.1% | 79.8% | 77.0% | 79.0% | 77.3% | 0.0% | 0.0% | 0.0% | 0.0% | 92.3% | 91.5% | 91.5% | 91.6% | 0.0% | 0.0% | 0.0% | 0.0% |\n| Short-term Business — Technical Margin | 116 | 191 | 107 | 206 | 93 | 141 | 83 | 158 | 11 | 25 | 11 | 24 | 0 | 0 | 0 | 0 | 12 | 25 | 13 | 25 | 0 | 0 | 0 | 0 |\n| Long-term Business — CSM Release | 1,136 | 2,253 | 1,158 | 2,415 | 407 | 823 | 419 | 895 | 390 | 759 | 386 | 804 | 4 | 3 | 0 | 1 | 336 | 669 | 353 | 715 | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | -71 | -98 | -28 | -139 | -40 | -96 | -37 | -81 | -4 | 12 | 13 | -53 | 3 | 2 | 0 | -5 | -30 | -16 | -4 | 0 | 0 | 0 | 0 | 0 |\n| Long-term Business — Actual vs. Expected Cash Flows | -4 | -33 | 10 | 37 | 8 | -8 | 2 | 15 | 3 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | -12 | -10 | 20 | 33 | 0 | 0 | 0 | 0 |\n| Long-term Business — Risk Adjustment Release | 25 | 51 | 37 | 59 | 5 | 15 | 9 | 14 | 12 | 23 | 20 | 30 | 0 | 1 | 0 | 1 | 8 | 13 | 8 | 14 | 0 | 0 | 0 | 0 |\n| Long-term Business — Changes in Onerous Contracts | -30 | 9 | -10 | -25 | 0 | 0 | 0 | 0 | -32 | -23 | -13 | -33 | 5 | 5 | 0 | 0 | -3 | 26 | 3 | 8 | 0 | 0 | 0 | 0 |\n| Long-term Business — Other Long-term | -63 | -124 | -65 | -211 | -52 | -103 | -49 | -111 | 13 | 23 | 17 | -44 | 0 | 0 | 0 | 0 | -23 | -45 | -34 | -55 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 454 | 799 | 462 | 738 | 103 | 193 | 114 | 185 | 249 | 432 | 232 | 401 | 10 | 19 | 10 | 20 | 92 | 155 | 105 | 132 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Investment Income | 1,159 | 2,209 | 1,159 | 2,142 | 344 | 660 | 346 | 649 | 451 | 838 | 438 | 809 | 13 | 27 | 14 | 27 | 350 | 684 | 361 | 657 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -705 | -1,410 | -697 | -1,405 | -241 | -467 | -232 | -464 | -202 | -407 | -206 | -408 | -3 | -7 | -4 | -8 | -259 | -530 | -256 | -525 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 1,634 | 3,145 | 1,699 | 3,219 | 563 | 1,060 | 579 | 1,156 | 645 | 1,227 | 643 | 1,176 | 17 | 25 | 10 | 16 | 409 | 833 | 468 | 872 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Tax | -316 | -635 | -329 | -584 | -96 | -194 | -93 | -213 | -148 | -289 | -131 | -183 | -3 | 0 | -2 | -4 | -68 | -152 | -103 | -184 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 101 | 182 | 93 | 154 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97 | 173 | 93 | 154 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | -27 | -56 | -30 | -75 | 0 | 0 | 0 | 0 | -23 | -47 | -28 | -70 | 0 | 0 | 0 | 0 | -4 | -9 | -3 | -5 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 1,392 | 2,636 | 1,433 | 2,715 | 470 | 875 | 486 | 943 | 474 | 891 | 484 | 923 | 14 | 25 | 8 | 12 | 434 | 845 | 456 | 837 | 0 | 0 | 0 | 0 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 157 | 96 | 105 | 21 | 23 | -19 | 4 | -41 | -3 | -14 | -35 | -24 | 0 | 0 | 0 | 0 | 137 | 129 | 137 | 86 | 0 | 0 | 0 | 0 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 11,589 | 11,778 | 11,623 | 11,205 | 11,349 | 11,502 | 11,352 | 10,939 | 75 | 120 | 118 | 124 | 0 | 0 | 0 | 0 | 165 | 157 | 154 | 142 | 0 | 0 | 0 | 0 |\n| **For long-term business — Best Estimate Liabilities net of reinsurance** | 275,276 | 285,391 | 280,314 | 280,280 | 112,949 | 115,280 | 114,525 | 114,424 | 114,389 | 117,841 | 116,058 | 115,433 | 324 | 345 | 310 | 309 | 47,614 | 51,926 | 49,420 | 50,113 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w VFA Gross of reinsurance | 243,037 | 251,273 | 244,964 | 250,326 | 116,132 | 117,942 | 116,770 | 117,266 | 100,727 | 103,800 | 99,267 | 101,144 | 0 | 0 | 0 | 0 | 26,178 | 29,530 | 28,928 | 31,916 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w BBA Gross of reinsurance | 50,917 | 52,713 | 52,731 | 46,724 | 9,606 | 10,019 | 9,848 | 8,873 | 13,770 | 14,107 | 16,752 | 14,106 | 1,670 | 1,659 | 1,522 | 1,473 | 25,871 | 26,927 | 24,608 | 22,272 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w Reinsurance | -18,679 | -18,595 | -17,381 | -16,770 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,435 | -4,532 | -4,116 | -4,074 | 0 | 0 | 0 | 0 |" |
||
}, |
}, |
||
{ |
{ |
||
| Line 277: | Line 308: | ||
"AXA Europe", |
"AXA Europe", |
||
"AXA XL", |
"AXA XL", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Transversal \u0026 Other", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
| Line 284: | Line 317: | ||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
"AXA", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Europe", |
"AXA Europe", |
||
"AXA France", |
"AXA France", |
||
"AXA Transversal \u0026 Other", |
|||
"AXA XL", |
"AXA XL", |
||
"Full year 2024", |
"Full year 2024", |
||
| Line 292: | Line 327: | ||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Health underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM 1H24 | Asia, Africa \u0026 EME-LATAM FY24 | Asia, Africa \u0026 EME-LATAM 1H25 | Asia, Africa \u0026 EME-LATAM FY25 | Transversal \u0026 Other 1H24 | Transversal \u0026 Other FY24 | Transversal \u0026 Other 1H25 | Transversal \u0026 Other FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 5,867 | 11,960 | 6,301 | 12,972 | 2,752 | 5,661 | 2,865 | 5,744 | 1,725 | 3,495 | 1,997 | 4,314 | 0 | 0 | 0 | 0 | 1,300 | 2,629 | 1,350 | 2,742 | 90 | 174 | 88 | 172 |\n| Short-term Business — Combined Ratio | 98.6% | 98.1% | 97.8% | 97.9% | 97.8% | 97.9% | 98.5% | 98.1% | 99.4% | 97.5% | 96.9% | 95.2% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 98.3% | 102.3% | 92.2% | 89.1% | 83.6% | 86.7% |\n| Short-term Business — Technical Margin | 79 | 224 | 141 | 273 | 62 | 117 | 42 | 108 | 10 | 88 | 62 | 206 | 0 | 0 | 0 | 0 | 1 | 1 | 23 | -64 | 7 | 19 | 14 | 23 |\n| Long-term Business — CSM Release | 259 | 522 | 270 | 539 | 0 | 0 | 0 | 0 | 78 | 161 | 84 | 180 | 0 | 0 | 0 | 0 | 180 | 360 | 186 | 359 | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | 7 | 3 | -2 | -11 | 0 | 0 | 0 | 0 | -6 | -20 | -5 | -17 | 0 | 0 | 0 | 0 | 14 | 23 | 3 | 6 | 0 | 0 | 0 | 0 |\n| Long-term Business — Actual vs. Expected Cash Flows | 13 | 18 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 18 | 2 | 2 | 0 | 0 | 0 | 0 |\n| Long-term Business — Risk Adjustment Release | 4 | 8 | 7 | 13 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 3 | 0 | 0 | 0 | 0 | 5 | 10 | 5 | 11 | 0 | 0 | 0 | 0 |\n| Long-term Business — Changes in Onerous Contracts | -1 | -2 | -2 | -4 | 0 | 0 | 0 | 0 | -1 | -2 | 0 | -3 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |\n| Long-term Business — Other Long-term | -8 | -21 | -9 | -22 | 0 | 0 | 0 | 0 | -6 | -16 | -6 | -16 | 0 | 0 | 0 | 0 | -2 | -5 | -3 | -5 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 82 | 176 | 101 | 209 | -3 | -1 | 4 | 12 | 35 | 72 | 37 | 76 | 0 | 0 | 0 | 0 | 51 | 105 | 60 | 118 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Investment Income | 160 | 317 | 170 | 341 | 26 | 41 | 24 | 55 | 39 | 77 | 40 | 79 | 0 | 0 | 0 | 0 | 95 | 198 | 106 | 205 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -78 | -140 | -69 | -133 | -29 | -43 | -20 | -42 | -4 | -5 | -4 | -3 | 0 | 0 | 0 | 0 | -45 | -93 | -45 | -87 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 427 | 925 | 510 | 1,010 | 59 | 116 | 46 | 120 | 117 | 302 | 178 | 446 | 0 | 0 | 0 | 0 | 245 | 489 | 272 | 419 | 7 | 19 | 14 | 25 |\n| Debt Financing Charges — Tax | -96 | -239 | -133 | -216 | -10 | -27 | -7 | -24 | -31 | -87 | -46 | -101 | 0 | 0 | 0 | 0 | -55 | -125 | -80 | -88 | 0 | 0 | -1 | -4 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | 0 | -4 | -3 | -9 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | -3 | -3 | -6 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 333 | 687 | 381 | 787 | 49 | 89 | 39 | 96 | 85 | 213 | 132 | 341 | 0 | 0 | 0 | 0 | 192 | 366 | 197 | 328 | 7 | 19 | 14 | 22 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 2,289 | 2,000 | 2,750 | 2,490 | 27 | 18 | 24 | 35 | 1,231 | 981 | 1,654 | 1,375 | 0 | 0 | 0 | 0 | 1,022 | 995 | 1,067 | 1,069 | 9 | 6 | 5 | 10 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 2,286 | 2,384 | 2,337 | 3,386 | 1,240 | 1,329 | 1,091 | 1,911 | 698 | 751 | 898 | 1,062 | 0 | 0 | 0 | 0 | 336 | 290 | 334 | 398 | 13 | 14 | 15 | 15 |\n| **For long-term business — Best Estimate Liabilities net of reinsurance** | 20,066 | 20,858 | 20,726 | 20,112 | 0 | 0 | 0 | 0 | 20,645 | 21,416 | 21,527 | 21,291 | 0 | 0 | 0 | 0 | -579 | -557 | -800 | -1,180 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w VFA Gross of reinsurance | 20,977 | 21,821 | 21,996 | 21,576 | 0 | 0 | 0 | 0 | 20,896 | 21,713 | 21,868 | 21,637 | 0 | 0 | 0 | 0 | 81 | 109 | 128 | -62 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w BBA Gross of reinsurance | -821 | -868 | -1,207 | -1,417 | 0 | 0 | 0 | 0 | -250 | -297 | -342 | -346 | 0 | 0 | 0 | 0 | -571 | -571 | -866 | -1,071 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w Reinsurance | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 |" |
"content": "**Health underlying earnings build-up by geography**\n\n| In EUR million | Total 1H24 | Total FY24 (Full year 2024) | Total 1H25 | Total FY25 (Full year 2025) | France (AXA France) 1H24 | France (AXA France) FY24 | France (AXA France) 1H25 | France (AXA France) FY25 | Europe (AXA Europe) 1H24 | Europe (AXA Europe) FY24 | Europe (AXA Europe) 1H25 | Europe (AXA Europe) FY25 | AXA XL 1H24 | AXA XL FY24 | AXA XL 1H25 | AXA XL FY25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY24 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) 1H25 | Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) FY25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY24 | Transversal \u0026 Other (AXA Transversal \u0026 Other) 1H25 | Transversal \u0026 Other (AXA Transversal \u0026 Other) FY25 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Short-term Business — Revenues | 5,867 | 11,960 | 6,301 | 12,972 | 2,752 | 5,661 | 2,865 | 5,744 | 1,725 | 3,495 | 1,997 | 4,314 | 0 | 0 | 0 | 0 | 1,300 | 2,629 | 1,350 | 2,742 | 90 | 174 | 88 | 172 |\n| Short-term Business — Combined Ratio | 98.6% | 98.1% | 97.8% | 97.9% | 97.8% | 97.9% | 98.5% | 98.1% | 99.4% | 97.5% | 96.9% | 95.2% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 98.3% | 102.3% | 92.2% | 89.1% | 83.6% | 86.7% |\n| Short-term Business — Technical Margin | 79 | 224 | 141 | 273 | 62 | 117 | 42 | 108 | 10 | 88 | 62 | 206 | 0 | 0 | 0 | 0 | 1 | 1 | 23 | -64 | 7 | 19 | 14 | 23 |\n| Long-term Business — CSM Release | 259 | 522 | 270 | 539 | 0 | 0 | 0 | 0 | 78 | 161 | 84 | 180 | 0 | 0 | 0 | 0 | 180 | 360 | 186 | 359 | 0 | 0 | 0 | 0 |\n| Long-term Business — Technical Experience | 7 | 3 | -2 | -11 | 0 | 0 | 0 | 0 | -6 | -20 | -5 | -17 | 0 | 0 | 0 | 0 | 14 | 23 | 3 | 6 | 0 | 0 | 0 | 0 |\n| Long-term Business — Actual vs. Expected Cash Flows | 13 | 18 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 18 | 2 | 2 | 0 | 0 | 0 | 0 |\n| Long-term Business — Risk Adjustment Release | 4 | 8 | 7 | 13 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 3 | 0 | 0 | 0 | 0 | 5 | 10 | 5 | 11 | 0 | 0 | 0 | 0 |\n| Long-term Business — Changes in Onerous Contracts | -1 | -2 | -2 | -4 | 0 | 0 | 0 | 0 | -1 | -2 | 0 | -3 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |\n| Long-term Business — Other Long-term | -8 | -21 | -9 | -22 | 0 | 0 | 0 | 0 | -6 | -16 | -6 | -16 | 0 | 0 | 0 | 0 | -2 | -5 | -3 | -5 | 0 | 0 | 0 | 0 |\n| Financial Result \u0026 Other — Financial Result | 82 | 176 | 101 | 209 | -3 | -1 | 4 | 12 | 35 | 72 | 37 | 76 | 0 | 0 | 0 | 0 | 51 | 105 | 60 | 118 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Investment Income | 160 | 317 | 170 | 341 | 26 | 41 | 24 | 55 | 39 | 77 | 40 | 79 | 0 | 0 | 0 | 0 | 95 | 198 | 106 | 205 | 0 | 0 | 0 | 2 |\n| Financial Result \u0026 Other — Insurance Finance Expenses | -78 | -140 | -69 | -133 | -29 | -43 | -20 | -42 | -4 | -5 | -4 | -3 | 0 | 0 | 0 | 0 | -45 | -93 | -45 | -87 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Before Tax** | 427 | 925 | 510 | 1,010 | 59 | 116 | 46 | 120 | 117 | 302 | 178 | 446 | 0 | 0 | 0 | 0 | 245 | 489 | 272 | 419 | 7 | 19 | 14 | 25 |\n| Debt Financing Charges — Tax | -96 | -239 | -133 | -216 | -10 | -27 | -7 | -24 | -31 | -87 | -46 | -101 | 0 | 0 | 0 | 0 | -55 | -125 | -80 | -88 | 0 | 0 | -1 | -4 |\n| Debt Financing Charges — Income from Affiliates \u0026 Other | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 |\n| Debt Financing Charges — Minority Interests | 0 | -4 | -3 | -9 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | -3 | -3 | -6 | 0 | 0 | 0 | 0 |\n| **Debt Financing Charges — Underlying Earnings Group share (Underlying earnings)** | 333 | 687 | 381 | 787 | 49 | 89 | 39 | 96 | 85 | 213 | 132 | 341 | 0 | 0 | 0 | 0 | 192 | 366 | 197 | 328 | 7 | 19 | 14 | 22 |\n| **For short-term business — Liabilities for remaining coverage net of reinsurance** | 2,289 | 2,000 | 2,750 | 2,490 | 27 | 18 | 24 | 35 | 1,231 | 981 | 1,654 | 1,375 | 0 | 0 | 0 | 0 | 1,022 | 995 | 1,067 | 1,069 | 9 | 6 | 5 | 10 |\n| **For short-term business — Best Estimate for incurred Claims net of reinsurance** | 2,286 | 2,384 | 2,337 | 3,386 | 1,240 | 1,329 | 1,091 | 1,911 | 698 | 751 | 898 | 1,062 | 0 | 0 | 0 | 0 | 336 | 290 | 334 | 398 | 13 | 14 | 15 | 15 |\n| **For long-term business — Best Estimate Liabilities net of reinsurance** | 20,066 | 20,858 | 20,726 | 20,112 | 0 | 0 | 0 | 0 | 20,645 | 21,416 | 21,527 | 21,291 | 0 | 0 | 0 | 0 | -579 | -557 | -800 | -1,180 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w VFA Gross of reinsurance | 20,977 | 21,821 | 21,996 | 21,576 | 0 | 0 | 0 | 0 | 20,896 | 21,713 | 21,868 | 21,637 | 0 | 0 | 0 | 0 | 81 | 109 | 128 | -62 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w BBA Gross of reinsurance | -821 | -868 | -1,207 | -1,417 | 0 | 0 | 0 | 0 | -250 | -297 | -342 | -346 | 0 | 0 | 0 | 0 | -571 | -571 | -866 | -1,071 | 0 | 0 | 0 | 0 |\n| For long-term business — o/w Reinsurance | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 |" |
||
}, |
}, |
||
{ |
{ |
||
| Line 333: | Line 368: | ||
"Other revenue", |
"Other revenue", |
||
"AXA", |
"AXA", |
||
"Property \u0026 casualty", |
|||
"Life \u0026 health", |
|||
"AXA Investment Managers", |
"AXA Investment Managers", |
||
"Dividend" |
"Dividend" |
||
| Line 344: | Line 381: | ||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Life \u0026 health", |
|||
"Other revenue", |
"Other revenue", |
||
"Property \u0026 casualty", |
|||
"Underlying earnings" |
"Underlying earnings" |
||
], |
], |
||
"content": "**Holdings underlying earnings build-up (8)(footnote: Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.)**\n\n| In EUR million | 1H24 | FY24 (Full year 2024) | 1H25 | FY25 (Full year 2025) |\n| --- | --- | --- | --- | --- |\n| Financial Result | 181 | 402 | 228 | 422 |\n| Other Revenues | 522 | 1,050 | 607 | 1,149 |\n| Other Expenses | -925 | -1,986 | -1,075 | -2,107 |\n| Debt Financing Charges | -471 | -948 | -452 | -928 |\n| **Underlying Earnings Before Tax** | -693 | -1,482 | -692 | -1,464 |\n| Tax | 100 | 324 | 101 | 284 |\n| Income from Affiliates \u0026 Other | 0 | 0 | 0 | 0 |\n| Minority Interests | 0 | 0 | 0 | 0 |\n| **Underlying Earnings Group share (Underlying earnings)** | -592 | -1,157 | -591 | -1,180 |\n\n**Holdings cash balance rollforward**\n\n| In EUR billion | 1H24 | FY24 | 1H25 | FY25 |\n| --- | --- | --- | --- | --- |\n| Opening Cash Balance at AXA SA (9) | — | 4.0 | — | 4.0 |\n| Net cash remittance from subsidiaries (10) | — | 7.7 | — | 7.5 |\n| Property \u0026 Casualty | — | 4.0 | — | 5.1 |\n| Life \u0026 Health | — | 3.6 | — | 2.5 |\n| Asset Management (AXA Investment Managers) \u0026 Other | — | 0.1 | — | 0.0 |\n| Dividends | — | -4.4 | — | -4.6 |\n| Share buy-backs (11) | — | -1.8 | — | -4.7 |\n| Holding costs and interests | — | -1.3 | — | -1.3 |\n| Debt issuance | — | 0.1 | — | 1.6 |\n| M\u0026A and disposals | — | 0.0 | — | 3.8 |\n| Other | — | -0.3 | — | -0.7 |\n| Closing Cash Balance at AXA SA (9) | — | 4.0 | — | 5.6 |\n\n(8) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.\n(9) Includes liquid invested assets.\n(10) Includes exceptional cash remittances from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.4 billion in 2024) and AXA Life Europe (Euro +0.2 billion in 2024).\n(11) On top of annual share buy-back, includes Euro +3.5 billion share buy-back in 2025 to offset the earnings dilution resulting from the disposal of AXA IM and Euro +0.7 billion share buy-back in 2024 from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.5 billion) and AXA Life Europe (Euro +0.2 billion)." |
"content": "**Holdings underlying earnings build-up (8)(footnote: Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.)**\n\n| In EUR million | 1H24 | FY24 (Full year 2024) | 1H25 | FY25 (Full year 2025) |\n| --- | --- | --- | --- | --- |\n| Financial Result | 181 | 402 | 228 | 422 |\n| Other Revenues | 522 | 1,050 | 607 | 1,149 |\n| Other Expenses | -925 | -1,986 | -1,075 | -2,107 |\n| Debt Financing Charges | -471 | -948 | -452 | -928 |\n| **Underlying Earnings Before Tax** | -693 | -1,482 | -692 | -1,464 |\n| Tax | 100 | 324 | 101 | 284 |\n| Income from Affiliates \u0026 Other | 0 | 0 | 0 | 0 |\n| Minority Interests | 0 | 0 | 0 | 0 |\n| **Underlying Earnings Group share (Underlying earnings)** | -592 | -1,157 | -591 | -1,180 |\n\n**Holdings cash balance rollforward**\n\n| In EUR billion | 1H24 | FY24 | 1H25 | FY25 |\n| --- | --- | --- | --- | --- |\n| Opening Cash Balance at AXA SA (9) | — | 4.0 | — | 4.0 |\n| Net cash remittance from subsidiaries (10) | — | 7.7 | — | 7.5 |\n| Property \u0026 Casualty (Property \u0026 casualty) | — | 4.0 | — | 5.1 |\n| Life \u0026 Health (Life \u0026 health) | — | 3.6 | — | 2.5 |\n| Asset Management (AXA Investment Managers) \u0026 Other | — | 0.1 | — | 0.0 |\n| Dividends | — | -4.4 | — | -4.6 |\n| Share buy-backs (11) | — | -1.8 | — | -4.7 |\n| Holding costs and interests | — | -1.3 | — | -1.3 |\n| Debt issuance | — | 0.1 | — | 1.6 |\n| M\u0026A and disposals | — | 0.0 | — | 3.8 |\n| Other | — | -0.3 | — | -0.7 |\n| Closing Cash Balance at AXA SA (9) | — | 4.0 | — | 5.6 |\n\n(8) Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.\n(9) Includes liquid invested assets.\n(10) Includes exceptional cash remittances from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.4 billion in 2024) and AXA Life Europe (Euro +0.2 billion in 2024).\n(11) On top of annual share buy-back, includes Euro +3.5 billion share buy-back in 2025 to offset the earnings dilution resulting from the disposal of AXA IM and Euro +0.7 billion share buy-back in 2024 from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.5 billion) and AXA Life Europe (Euro +0.2 billion)." |
||
}, |
}, |
||
{ |
{ |
||
| Line 358: | Line 397: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
"Business |
"Business mix", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Property \u0026 casualty", |
|||
"Life \u0026 health", |
|||
"AXA Investment Managers", |
"AXA Investment Managers", |
||
"Gross written premiums", |
"Gross written premiums \u0026 other revenues", |
||
"Other revenue", |
|||
"AXA France", |
"AXA France", |
||
"AXA Europe", |
"AXA Europe", |
||
"AXA XL" |
"AXA XL", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Transversal \u0026 Other" |
|||
], |
], |
||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
"AXA", |
||
"AXA Asia, Africa \u0026 EME-LATAM", |
|||
"AXA Europe", |
"AXA Europe", |
||
"AXA France", |
"AXA France", |
||
"AXA Investment Managers", |
"AXA Investment Managers", |
||
"AXA Transversal \u0026 Other", |
|||
"AXA XL", |
"AXA XL", |
||
"Business |
"Business mix", |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025", |
"Full year 2025", |
||
"Gross written premiums", |
"Gross written premiums \u0026 other revenues", |
||
" |
"Life \u0026 health", |
||
"Property \u0026 casualty" |
|||
], |
], |
||
"content": "**Activity indicators by line of business (Business |
"content": "**Activity indicators by line of business (Business mix)**\n\n| In EUR million | 1H24 Total | 1H24 P\u0026C (Property \u0026 casualty) | 1H24 Life \u0026 Health (Life \u0026 health) | 1H24 o/w Employee Benefits (12) | 1H24 Life | 1H24 Health | 1H24 Asset Management (AXA Investment Managers) | 1H24 Bank | FY24 (Full year 2024) Total | FY24 (Full year 2024) P\u0026C | FY24 (Full year 2024) Life \u0026 Health | FY24 (Full year 2024) o/w Employee Benefits (12) | FY24 (Full year 2024) Life | FY24 (Full year 2024) Health | FY24 (Full year 2024) Asset Management | FY24 (Full year 2024) Bank | 1H25 Total | 1H25 P\u0026C | 1H25 Life \u0026 Health | 1H25 o/w Employee Benefits (12) | 1H25 Life | 1H25 Health | 1H25 Asset Management | 1H25 Bank | FY25 (Full year 2025) Total | FY25 (Full year 2025) P\u0026C | FY25 (Full year 2025) Life \u0026 Health | FY25 (Full year 2025) o/w Employee Benefits (12) | FY25 (Full year 2025) Life | FY25 (Full year 2025) Health | FY25 (Full year 2025) Asset Management | FY25 (Full year 2025) Bank |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Gross Written Premiums \u0026 Other Revenues (Gross written premiums \u0026 other revenues) | 59,872 | 32,522 | 26,505 | 6,673 | 17,419 | 9,086 | 787 | 57 | 110,316 | 56,514 | 51,983 | 12,167 | 34,497 | 17,486 | 1,701 | 118 | 64,251 | 34,097 | 29,230 | 7,223 | 19,081 | 10,149 | 875 | 49 | 115,524 | 58,038 | 56,512 | 12,867 | 37,499 | 19,014 | 875 | 99 |\n| IFRS17/9 New Business Value (NBV) (a) | 1,206 | — | 1,206 | — | 953 | 253 | — | — | 2,264 | — | 2,264 | — | 1,792 | 473 | — | — | 1,189 | — | 1,189 | — | 928 | 260 | — | — | 2,233 | — | 2,233 | — | 1,747 | 486 | — | — |\n| New Business Contractual Service Margin (NB CSM) | 1,131 | — | 1,131 | — | 919 | 213 | — | — | 2,169 | — | 2,169 | — | 1,770 | 399 | — | — | 1,184 | — | 1,184 | — | 950 | 234 | — | — | 2,199 | — | 2,199 | — | 1,822 | 377 | — | — |\n| Other NBV (13) | 456 | — | 456 | — | 333 | 123 | — | — | 824 | — | 824 | — | 594 | 231 | — | — | 382 | — | 382 | — | 270 | 113 | — | — | 757 | — | 757 | — | 491 | 266 | — | — |\n| Tax | -381 | — | -381 | — | -299 | -83 | — | — | -729 | — | -729 | — | -572 | -158 | — | — | -378 | — | -378 | — | -292 | -86 | — | — | -724 | — | -724 | — | -567 | -157 | — | — |\n| Present Value of Expected Premiums (PVEP) (b) | 25,588 | — | 25,588 | — | 18,234 | 7,354 | — | — | 50,896 | — | 50,896 | — | 36,860 | 14,036 | — | — | 25,918 | — | 25,918 | — | 19,487 | 6,430 | — | — | 49,357 | — | 49,357 | — | 37,103 | 12,254 | — | — |\n| IFRS17/9 NBV Margin (a)/(b) | 4.7% | — | 4.7% | — | 5.2% | 3.4% | — | — | 4.4% | — | 4.4% | — | 4.9% | 3.4% | — | — | 4.6% | — | 4.6% | — | 4.8% | 4.0% | — | — | 4.5% | — | 4.5% | — | 4.7% | 4.0% | — | — |\n\n**Activity indicators by geography**\n\n| In EUR million | 1H24 Total | 1H24 France (AXA France) | 1H24 Europe (AXA Europe) | 1H24 AXA XL | 1H24 Asia, Africa \u0026 EME-LATAM (AXA Asia, Africa \u0026 EME-LATAM) | 1H24 AXA IM | 1H24 Transversal \u0026 Other (AXA Transversal \u0026 Other) | FY24 Total | FY24 France | FY24 Europe | FY24 AXA XL | FY24 Asia, Africa \u0026 EME-LATAM | FY24 AXA IM | FY24 Transversal \u0026 Other | 1H25 Total | 1H25 France | 1H25 Europe | 1H25 AXA XL | 1H25 Asia, Africa \u0026 EME-LATAM | 1H25 AXA IM | 1H25 Transversal \u0026 Other | FY25 Total | FY25 France | FY25 Europe | FY25 AXA XL | FY25 Asia, Africa \u0026 EME-LATAM | FY25 AXA IM | FY25 Transversal \u0026 Other |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| Gross Written Premiums \u0026 Other Revenues | 59,872 | 14,719 | 22,579 | 11,220 | 9,571 | 787 | 995 | 110,316 | 28,996 | 39,298 | 19,383 | 19,083 | 1,701 | 1,856 | 64,251 | 15,670 | 24,649 | 11,749 | 10,302 | 875 | 1,006 | 115,524 | 30,598 | 43,005 | 19,277 | 19,925 | 875 | 1,844 |\n| IFRS17/9 New Business Value (NBV) (a) | 1,206 | 354 | 348 | — | 504 | — | — | 2,264 | 682 | 597 | — | 986 | — | — | 1,189 | 315 | 364 | — | 510 | — | — | 2,233 | 695 | 578 | — | 959 | — | — |\n| New Business Contractual Service Margin (NB CSM) | 1,131 | 203 | 398 | — | 531 | — | — | 2,169 | 391 | 731 | — | 1,047 | — | — | 1,184 | 199 | 443 | — | 541 | — | — | 2,199 | 431 | 740 | — | 1,028 | — | — |\n| Other NBV (13) | 456 | 275 | 50 | — | 131 | — | — | 824 | 528 | 49 | — | 247 | — | — | 382 | 225 | 28 | — | 129 | — | — | 757 | 506 | 12 | — | 239 | — | — |\n| Tax | -381 | -123 | -100 | — | -158 | — | — | -729 | -237 | -184 | — | -309 | — | — | -378 | -109 | -107 | — | -161 | — | — | -724 | -242 | -174 | — | -308 | — | — |\n| Present Value of Expected Premiums (PVEP) (b) | 25,588 | 12,301 | 6,317 | — | 6,971 | — | — | 50,896 | 25,370 | 11,831 | — | 13,695 | — | — | 25,918 | 11,662 | 6,843 | — | 7,413 | — | — | 49,357 | 22,858 | 12,651 | — | 13,847 | — | — |\n| IFRS17/9 NBV Margin (a)/(b) | 4.7% | 2.9% | 5.5% | — | 7.2% | — | — | 4.4% | 2.7% | 5.0% | — | 7.2% | — | — | 4.6% | 2.7% | 5.3% | — | 6.9% | — | — | 4.5% | 3.0% | 4.6% | — | 6.9% | — | — |\n\n(12) Employee Benefits include Group Protection and Group Health contracts.\n(13) Includes expected profits from short term Life \u0026 Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers." |
||
}, |
}, |
||
{ |
{ |
||
| Line 393: | Line 438: | ||
"links": [ |
"links": [ |
||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025" |
"Full year 2025" |
||
"AXA" |
|||
], |
], |
||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025" |
"Full year 2025" |
||
], |
], |
||
"content": "**Assets build-up**\n\n| In EUR billion | FY24 (Full year 2024) | FY25 (Full year 2025) |\n| --- | --- | --- |\n| Goodwill | 18.1 | 17.8 |\n| Other intangible assets | 4.4 | 4.4 |\n| **Total Intangible assets** | 22.6 | 22.2 |\n| Investments in real estate properties | 29.2 | 27.8 |\n| Financial investments | 418.2 | 401.8 |\n| Unit-linked Assets | 90.1 | 97.2 |\n| **Total Investments from Insurance activities** | 537.5 | 526.9 |\n| Investments from Non-Insurance Activities | 18.5 | 16.6 |\n| Equity Method investments | 1.5 | 1.5 |\n| Assets Arising from Insurance and Reinsurance Contracts Held | 26.1 | 23.9 |\n| Present Value of Future Cash Flows | 24.1 | 22.0 |\n| Contractual Service Margin | 1.4 | 1.4 |\n| Risk Adjustment | 0.5 | 0.5 |\n| Receivables and Other Assets | 24.1 | 21.9 |\n| Assets held for sale | 4.5 | 0.2 |\n| Cash and cash equivalents | 19.0 | 22.2 |\n| **Total Assets** | 653.8 | 635.5 |\n\n**Liabilities, non-controlling interests, and shareholders' equity build-up**\n\n| In EUR billion | FY24 | FY25 |\n| --- | --- | --- |\n| Shareholders' Equity group |
"content": "**Assets build-up**\n\n| In EUR billion | FY24 (Full year 2024) | FY25 (Full year 2025) |\n| --- | --- | --- |\n| Goodwill | 18.1 | 17.8 |\n| Other intangible assets | 4.4 | 4.4 |\n| **Total Intangible assets** | 22.6 | 22.2 |\n| Investments in real estate properties | 29.2 | 27.8 |\n| Financial investments | 418.2 | 401.8 |\n| Unit-linked Assets | 90.1 | 97.2 |\n| **Total Investments from Insurance activities** | 537.5 | 526.9 |\n| Investments from Non-Insurance Activities | 18.5 | 16.6 |\n| Equity Method investments | 1.5 | 1.5 |\n| Assets Arising from Insurance and Reinsurance Contracts Held | 26.1 | 23.9 |\n| Present Value of Future Cash Flows | 24.1 | 22.0 |\n| Contractual Service Margin | 1.4 | 1.4 |\n| Risk Adjustment | 0.5 | 0.5 |\n| Receivables and Other Assets | 24.1 | 21.9 |\n| Assets held for sale | 4.5 | 0.2 |\n| Cash and cash equivalents | 19.0 | 22.2 |\n| **Total Assets** | 653.8 | 635.5 |\n\n**Liabilities, non-controlling interests, and shareholders' equity build-up**\n\n| In EUR billion | FY24 | FY25 |\n| --- | --- | --- |\n| Shareholders' Equity group share | 49.9 | 47.2 |\n| Non-controlling Interests | 2.5 | 2.4 |\n| **Shareholders’ equity** | 52.5 | 49.6 |\n| Financing debt | 14.4 | 15.8 |\n| Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts | 477.0 | 470.4 |\n| Present Value of Future Cash Flows | 438.4 | 432.6 |\n| Contractual Service Margin | 35.3 | 34.7 |\n| Risk Adjustment | 3.3 | 3.1 |\n| Other Investment Contract Liabilities | 12.6 | 12.8 |\n| **Liabilities arising from insurance, reinsurance and investment contracts** | 489.6 | 483.2 |\n| Liabilities Arising from Non-Insurance Activities | 10.1 | 9.9 |\n| Provisions for risks and charges | 4.9 | 4.6 |\n| Payables and Other liabilities | 80.9 | 72.5 |\n| Liabilities held for sale | 1.4 | 0.0 |\n| **Total Liabilities, Non-controlling Interests and Shareholders' Equity** | 653.8 | 635.5 |" |
||
}, |
}, |
||
{ |
{ |
||
| Line 413: | Line 456: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
"Business |
"Business mix", |
||
"Full year 2024", |
"Full year 2024", |
||
" |
"Property \u0026 casualty", |
||
"Full year 2025" |
"Full year 2025" |
||
], |
], |
||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
" |
"Business mix", |
||
"Business unit", |
|||
"Full year 2024", |
"Full year 2024", |
||
"Full year 2025" |
"Full year 2025", |
||
"Property \u0026 casualty" |
|||
], |
], |
||
"content": "**Contractual Service Margin (CSM) rollforward by business unit**\n\n| In EUR million | FY23 Restated (14) | New Business CSM | Underlying Return on inforce | CSM Release | Economic Variance | Operating Variance | Other (15) | FY24 (Full year 2024) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Total Group |
"content": "**Contractual Service Margin (CSM) rollforward by business unit (Business mix)**\n\n| In EUR million | FY23 Restated (14) | New Business CSM | Underlying Return on inforce | CSM Release | Economic Variance | Operating Variance | Other (15) | FY24 (Full year 2024) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Total Group (pre-tax)** | 34,187 | 2,169 | 1,383 | -2,775 | -998 | 432 | -545 | 33,853 |\n| P\u0026C (Property \u0026 casualty) | 206 | 0 | 0 | 0 | 0 | 0 | 76 | 282 |\n| Life | 26,200 | 1,770 | 1,172 | -2,253 | -890 | 363 | -534 | 25,826 |\n| Health | 7,782 | 400 | 211 | -522 | -108 | 69 | -87 | 7,744 |\n| **Total Group (post-tax)** | 26,777 | — | — | — | — | — | — | 26,320 |\n\n**Contractual Service Margin (CSM) rollforward by business unit**\n\n| In EUR million | FY24 | New Business CSM | Underlying Return on inforce | CSM Release | Economic Variance | Operating Variance | Other (15) | FY25 (Full year 2025) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| **Total Group (pre-tax)** | 33,853 | 2,199 | 1,328 | -2,954 | 594 | -316 | -1,451 | 33,253 |\n| P\u0026C | 282 | 0 | 0 | 0 | 0 | 0 | -21 | 261 |\n| Life | 25,826 | 1,822 | 1,150 | -2,415 | 487 | -526 | -903 | 25,442 |\n| Health | 7,744 | 377 | 178 | -539 | 107 | 210 | -527 | 7,550 |\n| **Total Group (post-tax)** | 26,320 | — | — | — | — | — | — | 25,864 |\n\n(14) Following the termination of the sale of a closed life and pensions portfolio at AXA Germany in 2024. It was classified as held for sale in 2023.\n(15) Including scope changes and FX." |
||
}, |
}, |
||
{ |
{ |
||
| Line 469: | Line 512: | ||
"tags": [], |
"tags": [], |
||
"links": [ |
"links": [ |
||
"AXA", |
|||
"Full year 2025", |
"Full year 2025", |
||
"Dividend", |
"Dividend", |
||
| Line 476: | Line 518: | ||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
|||
"Capital management", |
"Capital management", |
||
"Dividend", |
"Dividend", |
||
| Line 482: | Line 523: | ||
"Full year 2025" |
"Full year 2025" |
||
], |
], |
||
"content": "**Change in Group |
"content": "**Change in Group Share Consolidated Shareholders' Equity rollforward**\n\n| In EUR billion | FY25 (Full year 2025) |\n| --- | --- |\n| **Shareholders' Equity at Beginning of the Period** | 49.9 |\n| Paid-in Capital | -4.9 |\n| Treasury Shares | -0.1 |\n| Other Comprehensive Income Arising from Defined Benefit Plans | -0.3 |\n| Fair Value Recorded in Shareholders' Equity | 1.3 |\n| Other Comprehensive Income Related to Invested Assets | -4.2 |\n| Other Comprehensive Income Related to (re) Insurance Contracts | 5.4 |\n| Impact of Currency Fluctuations | -3.5 |\n| Undated Subordinated Debt (including interest charges) | -0.3 |\n| Realized Gains on Equity through Retained Earnings | 0.1 |\n| Dividends | -4.6 |\n| Net Income for the Period | 9.8 |\n| Other | -0.2 |\n| **Shareholders' Equity at End of the Period** | 47.2 |\n\n**Group Share Consolidated Shareholders' Equity build-up**\n\n| In EUR billion | FY24 (Full year 2024) | FY25 |\n| --- | --- | --- |\n| Paid-in Capital | 21.8 | 16.9 |\n| Treasury Shares | -1.5 | -1.6 |\n| Other Comprehensive Income Arising from Defined Benefit Plans | -2.4 | -2.8 |\n| Other Comprehensive Income | -8.1 | -6.8 |\n| Other Comprehensive Income Related to Invested Assets | -13.1 | -17.3 |\n| Other Comprehensive Income Related to (re) Insurance Contracts | 5.0 | 10.5 |\n| Translation Reserves | -1.1 | -4.6 |\n| Undated Subordinated Debt | 4.8 | 4.6 |\n| Retained Earnings | 36.5 | 41.4 |\n| **Total Shareholders' Equity at the End of the Period** | 49.9 | 47.2 |\n\n**Book value per share and shareholders' equity plus CSM per share**\n\n| EUR | FY24 | FY25 |\n| --- | --- | --- |\n| Book Value per Share (25) | 24.5 | 24.0 |\n| Shareholders' Equity + CSM per Share (26) | 32.7 | 33.2 |\n\n**Unrealized gains and losses on invested assets net of tax build-up**\n\n| In EUR billion | FY24 | FY25 |\n| --- | --- | --- |\n| Government Bonds (recyclable) | -7.5 | -13.0 |\n| Corporate Bonds (recyclable) | -4.1 | -3.0 |\n| Cash Flow hedges (recyclable) | -3.5 | -3.3 |\n| Equities (non-recyclable) | 2.3 | 2.1 |\n| Others (recyclable) | -0.3 | -0.1 |\n| **Total Other Comprehensive Income Related to Invested Assets** | -13.1 | -17.3 |\n| Real Estate | 6.7 | 6.5 |\n| Other Invested Assets Not Included in Shareholders' Equity | -0.6 | -0.1 |\n| **Total Unrealized Gains and Losses on Invested Assets at Cost (Net of Tax)** | 6.1 | 6.4 |\n| **Total Unrealized Gains and Losses on Invested Assets (Net of Tax)** | -7.0 | -10.9 |\n\n(25) Shareholders' equity excludes the other comprehensive income as well as the undated and deeply subordinated debt.\n(26) Shareholders' equity excludes the undated and deeply subordinated debt. CSM is net of tax and Group Share." |
||
}, |
}, |
||
{ |
{ |
||
| Line 539: | Line 580: | ||
"links": [ |
"links": [ |
||
"Full year 2025", |
"Full year 2025", |
||
"Dividend" |
"Dividend" |
||
"AXA" |
|||
], |
], |
||
"data_items": [], |
"data_items": [], |
||
"effective_tags": [ |
"effective_tags": [ |
||
"AXA", |
|||
"Capital management", |
"Capital management", |
||
"Dividend", |
"Dividend", |
||
"Full year 2025" |
"Full year 2025" |
||
], |
], |
||
"content": "**Reconciliation IFRS 17/9 shareholders' equity to Solvency II eligible own funds**\n\n| In EUR billion | FY25 (Full year 2025) |\n| --- | --- |\n| **IFRS SHAREHOLDERS' EQUITY** | 49.6 |\n| Contractual Service Margin (net of tax) | 25.9 |\n| **IFRS SHAREHOLDERS' EQUITY inc. CSM** | 75.5 |\n| Net URCG not included in Shareholders' Equity | 6.4 |\n| Elimination Undated Subordinated Debts | -4.6 |\n| Elimination Intangibles | -21.3 |\n| Goodwill | -17.8 |\n| others | -3.5 |\n| **IFRS TANGIBLE NET ASSET VALUE** | 56.0 |\n| Foreseeable dividends and distribution | -6.3 |\n| Technical provision adjustments | -9.6 |\n| Risk Margin vs Risk Adjustment | -6.4 |\n| BEL adjustment | -3.2 |\n| Other adjustments | -0.6 |\n| **UNRESTRICTED TIER 1** | 39.6 |\n| Restricted Tier 1 + Tier 2 | 16.4 |\n| Tier 3 | 0.4 |\n| **GROUP |
"content": "**Reconciliation IFRS 17/9 shareholders' equity to Solvency II eligible own funds**\n\n| In EUR billion | FY25 (Full year 2025) |\n| --- | --- |\n| **IFRS SHAREHOLDERS' EQUITY** | 49.6 |\n| Contractual Service Margin (net of tax) | 25.9 |\n| **IFRS SHAREHOLDERS' EQUITY inc. CSM** | 75.5 |\n| Net URCG not included in Shareholders' Equity | 6.4 |\n| Elimination Undated Subordinated Debts | -4.6 |\n| Elimination Intangibles | -21.3 |\n| Goodwill | -17.8 |\n| others | -3.5 |\n| **IFRS TANGIBLE NET ASSET VALUE** | 56.0 |\n| Foreseeable dividends and distribution | -6.3 |\n| Technical provision adjustments | -9.6 |\n| Risk Margin vs Risk Adjustment | -6.4 |\n| BEL adjustment | -3.2 |\n| Other adjustments | -0.6 |\n| **UNRESTRICTED TIER 1** | 39.6 |\n| Restricted Tier 1 + Tier 2 | 16.4 |\n| Tier 3 | 0.4 |\n| **GROUP ELIGIBLE OWN FUNDS** | 56.4 |" |
||
} |
} |
||
], |
], |
||
Latest revision as of 23:47, 27 July 2026
| doc_id | "gr2rpazfcv" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| document |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| sections |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| title | "AXA/2025/FY/Financial supplement" | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| source_url | "https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_KkMFoBIGEg14b_AXA_Financial_Supplement_2025_synthesis.xlsx" |